Disorders of calcium metabolism

E4_CA_MET

calcium metabolic disease: Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E83.50, E83.50+F02.89, E83.50+N16.3, E83.51, E83.58, E83.59 Hospital discharge: ICD-9 — 2754 Cause of death: ICD-10 — E83.50, E83.50+F02.89, E83.50+N16.3, E83.51, E83.58, E83.59 Cause of death: ICD-9 — 2754 2 out of 7 registries used, show all original rules.	2364
4. Check minimum number of events None	2364
5. Include endpoints None	2364
6. Filter based on genotype QC (FinnGen only)	2364

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	E4_CA_MET
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E835
HD_ICD_9	2754
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E835
COD_ICD_9	2754
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of calcium metabolism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2364	1417	947
Unadjusted period prevalence (%)	0.46	0.48	0.42
Median age at first event (years)	63.96	62.82	65.67

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2118: Matched controls
21180

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E83.51

ICD-10 Finland

Hypocalcemia

2402.1

323.0

654

E83.50

ICD-10 Finland

Hypercalcemia

1408.9

323.0

1251

A11CC03

ATC

alfacalcidol; systemic

47.6

323.0

400

103

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

38.1

273.9

352

110

E83.58

ICD-10 Finland

Idiopathic hypercalciuria

+∞

197.0

186

E21.0

ICD-10 Finland

Primary hyperparathyroidism

34.2

195.1

257

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

+∞

174.4

165

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.7

170.4

1117

4887

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

66.6

167.9

194

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

31.7

154.4

207

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

34.3

147.6

194

A12AA04

ATC

calcium carbonate; oral

31.5

147.5

198

106

Kela drug reimbursment

Hypoparathyroidism

203.0

146.8

151

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

9.1

145.7

326

414

BAA60

NOMESCO Finland

Total thyroidectomy

17.8

137.5

221

138

E87.6

ICD-10 Finland

Hypokalaemia

34.1

131.6

173

C03CA01

ATC

furosemide; systemic

3.4

131.5

873

3637

N17.9

ICD-10 Finland

Acute renal failure, unspecified

11.2

112.2

221

218

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

108.0

1140

6236

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

71.7

106.8

122

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.5

102.1

329

682

A11CC02

ATC

dihydrotachysterol; oral

342.6

98.9

EP1AE

NOMESCO Finland

Neck ultrasound examination

5.8

86.1

262

502

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.1

86.0

375

1053

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

28.5

84.6

116

N18.8

ICD-10 Finland

Other chronic renal failure

11.5

83.2

160

149

M04AA01

ATC

allopurinol; systemic

3.7

82.9

420

1340

N02AA05

ATC

oxycodone; systemic

3.3

82.1

482

1723

H03AA01

ATC

levothyroxine sodium; systemic

2.8

80.8

679

3085

H05BX01

ATC

cinacalcet; oral

68.6

80.1

N19

ICD-10 Finland

Unspecified kidney failure

9.2

80.0

174

204

321

Kela drug reimbursment

Paricalcitol and cinacalcet

57.8

79.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.4

78.1

441

1525

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

12.8

77.3

141

117

E86

ICD-10 Finland

Volume depletion

70.4

77.0

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

12.5

76.9

142

121

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

+∞

75.5

104

Kela drug reimbursment

Thyroid insufficiency

4.5

75.1

292

729

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

7.4

71.8

180

264

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

19.1

71.7

111

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

71.4

408

1415

JN4AD

NOMESCO Finland

Body CT examination

4.1

70.6

299

808

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

68.6

741

3806

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

5.3

67.2

220

455

E83.59

ICD-10 Finland

Other disorders of calcium metabolism

+∞

67.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

64.2

425

1622

M05BX04

ATC

denosumab; parenteral

4.8

61.3

220

502

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

15.8

60.4

100

E87.5

ICD-10 Finland

Hyperkalaemia

55.6

59.1

E21.2

ICD-10 Finland

Other hyperparathyroidism

38.3

58.2

Z49.1

ICD-10 Finland

Extracorporeal dialysis

16.6

57.9

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.3

57.8

320

1070

A02BC02

ATC

pantoprazole; systemic

2.1

57.7

1439

10537

AA1AD

NOMESCO Finland

CT of head and brain

2.4

54.6

576

2854

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

53.7

299

1001

J01MA12

ATC

levofloxacin; systemic

2.5

53.2

487

2235

TK800

NOMESCO Finland

Hemodialysis

9.0

51.6

112

130

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.4

51.5

199

487

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

50.5

575

2943

B03XA02

ATC

darbepoetin alfa; parenteral

10.1

49.8

101

104

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

49.6

517

2531

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

49.4

776

4581

H02AB06

ATC

prednisolone; systemic

2.0

49.4

1060

7093

SPAT1262

SPAT

Handing over of treatment supplies

2.5

49.4

450

2051

N02BE01

ATC

paracetamol; systemic, rectal

2.4

48.6

1830

15343

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

29.9

47.7

XW000

NOMESCO Finland

Bone marrow biopsy

5.0

47.5

160

339

WW500

NOMESCO Finland

Blood transfusion

4.9

47.5

163

353

C08CA01

ATC

amlodipine; oral

2.0

46.8

806

4914

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

26.3

46.1

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

46.0

635

3524

E20.8

ICD-10 Finland

Other hypoparathyroidism

+∞

46.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.7

45.8

343

1391

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

45.8

495

2450

Z51.5

ICD-10 Finland

Palliative care

3.9

45.6

201

555

R50.9

ICD-10 Finland

Fever, unspecified

2.7

45.1

357

1496

R53

ICD-10 Finland

Malaise and fatigue

2.3

45.0

490

2430

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

44.7

509

2582

I10

ICD-10 Finland

Essential (primary) hypertension

1.9

44.2

1216

8776

BBA20

NOMESCO Finland

Exploration of parathyroid gland

40.3

43.9

Z94.0

ICD-10 Finland

Kidney transplant status

18.0

43.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.4

43.4

118

193

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.0

42.4

269

979

C07AB07

ATC

bisoprolol; oral

1.9

42.3

986

6663

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

13.4

42.0

A12AA06

ATC

calcium lactate gluconate; oral

149.7

41.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

5.1

41.9

137

281

N16.3*E83.50

ICD-10 Finland

Nefrocalcinosis NEC

+∞

41.8

WZC30

NOMESCO Finland

Teaching

2.6

41.5

352

1526

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

61.3

41.4

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.6

40.3

195

581

N18.0

ICD-10 Finland

End-stage renal disease

13.6

40.1

V03AE01

ATC

polystyrene sulfonate; oral

16.9

40.0

C90.0

ICD-10 Finland

Multiple myeloma

12.4

40.0

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

15.4

39.8

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

21.3

39.3

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.2

39.2

156

391

205

Kela drug reimbursment

Chronic hypertension

2.0

39.0

638

3747

N02AX02

ATC

tramadol; systemic, rectal

1.9

38.9

916

6148

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

38.5

38.8

ZX120

NOMESCO Finland

Intravenous

2.9

38.8

264

1001

196

Kela drug reimbursment

Paricalcitol and cinacalcet

64.1

38.2

JN3AD

NOMESCO Finland

Abdominal CT examination

3.2

37.9

213

711

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

37.5

506

2738

Z49.0

ICD-10 Finland

Preparatory care for dialysis

17.3

37.3

137

Kela drug reimbursment

Uraemia requiring dialysis

18.0

37.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.4

36.8

115

224

127

Kela drug reimbursment

Transplant complication

10.3

36.1

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

4.3

35.8

139

340

H03BB01

ATC

carbimazole; oral

4.7

35.2

125

280

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.5

35.0

107

203

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

5.9

34.9

100

175

2754A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]

+∞

34.5

JN4BD

NOMESCO Finland

Extensive body CT

2.5

34.4

291

1254

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

9.5

34.1

V03AE03

ATC

lanthanum carbonate; oral

94.1

33.8

A10AE04

ATC

insulin glargine; parenteral

3.0

33.8

214

774

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

5.1

33.8

111

229

SPAT1254

SPAT

Administration of medicine

2.3

33.2

350

1685

I50.9

ICD-10 Finland

Heart failure, unspecified

2.4

32.8

299

1337

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

32.7

219

821

R06.0

ICD-10 Finland

Dyspnoea

2.0

32.5

526

3037

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

8.3

32.4

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

9.6

31.9

H02AB02

ATC

dexamethasone; systemic

2.5

31.9

275

1193

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

31.7

481

2705

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

13.4

31.5

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

23.0

31.4

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

13.1

31.2

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

4.4

31.1

118

283

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

14.8

31.0

A41.9

ICD-10 Finland

Sepsis, unspecified

4.4

31.0

117

279

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.9

30.9

131

348

L04AA06

ATC

mycophenolic acid; systemic

7.9

30.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

30.8

246

1024

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

30.6

713

4663

A04AA01

ATC

ondansetron; systemic, rectal

3.0

30.4

190

680

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

30.4

490

2818

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

30.3

540

3217

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

25.2

30.1

J01DB01

ATC

cefalexin; oral

1.8

29.7

1660

14084

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.4

29.5

111

264

KH1AD

NOMESCO Finland

CT of urinary organs

4.3

29.5

112

269

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.8

29.2

207

802

B01AB10

ATC

tinzaparin; parenteral

2.9

29.0

190

700

L28

ICPC

Limited function/disability (L)

2.1

29.0

354

1813

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.6

28.9

138

406

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

5.6

28.8

159

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

28.8

835

5819

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

28.6

270

1224

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

28.6

216

867

N17.8

ICD-10 Finland

Other acute renal failure

11.5

28.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

28.3

351

1807

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.8

28.3

125

344

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.0

27.9

174

619

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

14.1

27.6

M05BA04

ATC

alendronic acid; oral

2.5

27.5

237

1025

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.7

27.4

206

823

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

7.6

27.4

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

23.3

27.4

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

7.1

27.3

WW200

NOMESCO Finland

Immunization

5.1

27.3

178

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

27.1

392

2146

V03AE02

ATC

sevelamer; oral

26.9

27.1

A06AD11

ATC

lactulose; oral

2.1

27.1

326

1656

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

4.9

27.1

193

Z49.2

ICD-10 Finland

Other dialysis

16.2

26.8

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

18.1

26.6

J01MA02

ATC

ciprofloxacin; systemic

1.7

26.6

801

5605

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

5.4

26.4

155

M10.9

ICD-10 Finland

Gout, unspecified

3.0

26.3

161

567

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

29.6

26.3

R11

ICD-10 Finland

Nausea and vomiting

2.7

26.3

187

726

UJF32

NOMESCO Finland

Coloscopy

1.8

26.1

561

3535

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

+∞

26.1

B05DA

ATC

Isotonic solutions

15.1

26.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

25.9

284

1381

SPAT1263

SPAT

Sampling

1.7

25.9

865

6220

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

25.8

343

1811

BBA50

NOMESCO Finland

Total parathyroidectomy

263.7

25.7

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.9

25.6

178

B05DB

ATC

Hypertonic solutions

16.0

25.4

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

25.4

25.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

25.0

242

1107

C03AA03

ATC

hydrochlorothiazide; oral

2.4

25.0

229

1020

N03AX16

ATC

pregabalin; oral

1.8

24.9

495

3036

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

70.7

24.8

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.9

24.7

156

559

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

131.5

24.6

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

24.6

248

1159

C02AC05

ATC

moxonidine; oral

3.6

24.6

116

338

C03DA01

ATC

spironolactone; oral

2.4

24.6

229

1028

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

24.5

155

558

N20.0

ICD-10 Finland

Calculus of kidney

5.0

24.5

165

C10AA05

ATC

atorvastatin; oral

1.7

24.5

711

4893

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

8.9

24.3

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

15.9

24.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

23.9

306

1592

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

23.8

184

747

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

31.4

23.7

153

Kela drug reimbursment

Lenalidomid

12.6

23.6

XX3DW

NOMESCO Finland

Time consuming IT work

2.2

23.5

245

1164

UKC02

NOMESCO Finland

Cystoscopy

2.0

23.1

349

1937

SPAT1229

SPAT

Assessment of need for aid

2.4

22.9

203

890

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.2

22.8

215

A10BH05

ATC

linagliptin; oral

3.4

22.8

116

359

D86.0

ICD-10 Finland

Sarcoidosis of lung

6.7

22.8

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.9

22.7

143

514

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

22.6

342

1895

130

Kela drug reimbursment

Malignant tumour

2.4

22.5

203

895

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

15.9

22.4

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

8.7

22.3

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

22.3

112

343

B01AB05

ATC

enoxaparin; parenteral

1.7

22.2

624

4228

T90

ICPC

Diabetes non-insulin dependent

1.8

22.0

443

2712

E83.5

ICD-10 Finland

Disorders of calcium metabolism

+∞

21.9

U14

ICPC

Kidney symptom/complaint

6.4

21.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

21.3

115

372

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

21.1

174

732

SPAT1216

SPAT

Assessment of functional ability

1.9

20.9

339

1925

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

18.0

20.9

H02AB09

ATC

hydrocortisone; systemic

4.6

20.8

163

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

20.8

340

1935

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.3

20.7

187

E61.2

ICD-10 Finland

Magnesium deficiency

77.6

20.7

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

4.9

20.7

142

B03XA01

ATC

erythropoietin; parenteral

9.1

20.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

20.5

373

2202

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.5

20.4

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

20.4

252

1285

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

20.4

297

1616

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

22.6

20.4

WX402

NOMESCO Finland

General anaesthesia

1.9

20.3

331

1882

GD1AD

NOMESCO Finland

Thorax CT examination

3.1

19.9

110

362

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.8

19.9

133

496

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

+∞

19.8

E87.2

ICD-10 Finland

Acidosis

+∞

19.8

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

4.3

19.8

181

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.1

19.7

113

382

N20.1

ICD-10 Finland

Calculus of ureter

3.2

19.5

104

334

A04AA02

ATC

granisetron; systemic, transdermal

2.6

19.4

150

610

B01AC04

ATC

clopidogrel; oral

2.0

19.3

258

1356

A04

ICPC

Weakness/tiredness general

2.0

19.2

258

1361

A10AE05

ATC

insulin detemir; parenteral

3.0

19.2

115

398

L04AX04

ATC

lenalidomide; oral

11.1

19.2

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

18.9

146

593

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

4.7

18.9

138

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

9.2

18.9

C07AB02

ATC

metoprolol; systemic

1.7

18.8

427

2697

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.9

18.7

201

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

7.2

18.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

18.6

544

3696

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

18.6

846

6409

C08CA13

ATC

lercanidipine; oral

2.0

18.6

270

1469

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

6.6

18.4

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

13.0

18.4

TK810

NOMESCO Finland

Hemofiltration

13.0

18.4

N03AX12

ATC

gabapentin; oral

1.9

18.4

317

1831

N05BA04

ATC

oxazepam; oral

1.7

18.3

478

3148

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

4.1

18.3

176

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

18.3

135

535

L03AA02

ATC

filgrastim; parenteral

3.8

18.2

211

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

14.5

18.1

C09AA02

ATC

enalapril; systemic

1.7

18.0

391

2436

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

18.0

679

4913

J01FF01

ATC

clindamycin; systemic

1.6

17.9

528

3588

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

17.9

576

4006

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

7.2

17.8

K92.1

ICD-10 Finland

Melaena

2.8

17.6

117

437

N05CF01

ATC

zopiclone; oral

1.6

17.5

644

4623

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

17.4

152

660

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

17.3

409

2609

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

17.3

110

398

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

12.7

17.1

C10AA01

ATC

simvastatin; oral

1.5

17.1

775

5836

A02BC05

ATC

esomeprazole; systemic

1.5

17.0

785

5930

N16.2*D86.8

ICD-10 Finland

Renal tubulo-interstitial disorders in sarcoidosis

50.4

17.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.6

16.9

127

509

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

5.1

16.7

103

J01MA14

ATC

moxifloxacin; systemic

2.1

16.6

195

971

WX892

NOMESCO Finland

Monitored bed care

2.4

16.5

146

639

A28

ICPC

Limited function/disability NOS

1.8

16.5

294

1715

WX882

NOMESCO Finland

High dependency care

3.7

16.4

205

A02BC01

ATC

omeprazole; systemic

1.6

16.4

548

3833

SPAT1255

SPAT

Intravenous administration of medicine

2.4

16.3

147

648

N06AX11

ATC

mirtazapine; oral

1.6

16.3

593

4230

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

16.3

868

6747

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.9

16.2

111

A12BA01

ATC

potassium chloride; oral

2.7

16.2

115

446

A06AH03

ATC

naloxegol; oral

6.4

16.1

H02AB04

ATC

methylprednisolone; systemic

1.8

16.1

298

1763

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

16.0

248

1378

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

24.7

16.0

SPAT1234

SPAT

Support of social functional capacity

2.6

15.9

117

461

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.8

15.9

180

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

17.3

15.6

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

26.5

15.6

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.7

15.6

193

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

15.5

290

1718

AN1

Coronary angiography

2.1

15.5

193

984

329

Kela drug reimbursment

Lenalidomide

13.8

15.5

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

9.5

15.4

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

4.6

15.3

114

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

11.3

15.3

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

15.2

138

613

A10BA02

ATC

metformin; oral

1.6

15.2

498

3455

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

15.2

487

3360

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

7.8

15.1

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.5

15.0

115

467

WX002

NOMESCO Finland

Sedation and analgesia

1.6

14.9

393

2575

B03BA03

ATC

hydroxocobalamin; parenteral

2.4

14.8

129

558

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

14.8

567

4078

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

5.9

14.8

H02AB07

ATC

prednisone; oral

1.8

14.8

290

1742

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

14.8

390

2556

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

4.4

14.7

123

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

14.6

260

1512

N16.3

ICD-10 Finland

Renal tubulo-interstitial disorders in metabolic diseases

+∞

14.6

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.8

14.6

163

A46

ICD-10 Finland

Erysipelas

1.8

14.6

266

1561

A09AA02

ATC

multienzymes (lipase, protease etc.)

4.3

14.5

125

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

14.4

105

414

WX730

NOMESCO Finland

Conventional respirator

5.3

14.4

L04AD01

ATC

ciclosporin; systemic

4.7

14.3

104

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.7

14.3

104

I50.0

ICD-10 Finland

Congestive heart failure

2.3

14.3

136

615

R4190

NOMESCO Finland

Nutritional therapy

3.1

14.2

258

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

7.7

14.1

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

14.1

382

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

12.0

14.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

14.1

334

2123

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.5

14.1

N30.0

ICD-10 Finland

Acute cystitis

1.8

14.0

267

1589

ZXA10

NOMESCO Finland

Bilateral

1.6

14.0

375

2466

TGC00

NOMESCO Finland

Bronchial lavation

3.2

13.9

228

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.4

13.9

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

13.9

745

5743

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.4

13.9

212

Kela drug reimbursment

Gout

3.8

13.9

155

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

13.9

155

755

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

11.5

13.8

3025

Kela drug reimbursment

Calcium carbonate

20.2

13.8

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

13.7

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

13.7

145

691

N05AH04

ATC

quetiapine; oral

1.8

13.7

267

1600

SPAT1301

SPAT

No procedures

1.5

13.6

610

4524

R13

ICD-10 Finland

Dysphagia

2.2

13.6

144

685

WX110

NOMESCO Finland

Local anesthesy

1.4

13.6

1289

11057

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

13.6

307

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

13.6

129

585

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

13.5

204

1119

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

13.5

373

K08.3

ICD-10 Finland

Retained dental root

2.2

13.5

144

690

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

13.5

112

475

WX872

NOMESCO Finland

Intensive care

2.6

13.5

375

SPAT1310

SPAT

Counselling related to known health issue

1.5

13.4

609

4529

P01AB01

ATC

metronidazole; oral, rectal

1.5

13.4

727

5607

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

25.9

13.4

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.0

13.3

136

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

13.3

685

5228

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.9

13.2

294

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

13.2

506

3626

N06AX16

ATC

venlafaxine; oral

1.8

13.2

236

1376

ZX108

NOMESCO Finland

Inhalation

7.6

13.2

ZX112

NOMESCO Finland

Subcutaneous

3.6

13.1

168

132

Kela drug reimbursment

Sarcoidosis

6.9

13.1

TK820

NOMESCO Finland

Peritoneal dialysis

12.2

13.1

ZX114

NOMESCO Finland

Intramuscular

4.7

13.1

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.6

13.1

169

RD210

NOMESCO Finland

4.5

13.0

101

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

13.0

336

2184

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

9.4

13.0

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

12.9

105

440

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

12.8

204

1141

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

50.3

12.8

A10BB12

ATC

glimepiride; oral

2.2

12.8

137

657

JN6AD

NOMESCO Finland

CT of torso and neck

5.0

12.8

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

12.7

399

A41.8

ICD-10 Finland

Other specified sepsis

4.5

12.7

KAE12

NOMESCO Finland

Retrograde ureteronephroscopic lithotripsy in pelvis of kidney

9.7

12.7

AA1AA

NOMESCO Finland

Head X-ray examination

6.0

12.7

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.8

12.7

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.5

12.7

401

A10BH01

ATC

sitagliptin; oral

2.0

12.7

168

880

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

12.6

142

696

197

Kela drug reimbursment

Sunitinib

15.5

12.6

V03AG01

ATC

sodium cellulose phosphate; systemic

70.3

12.6

SPAT1167

SPAT

Insertion of urinary catheter

3.0

12.5

246

C08CA02

ATC

felodipine; oral

1.9

12.5

181

981

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

12.5

560

4144

L95

ICPC

Osteoporosis

2.8

12.5

305

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

20.2

12.4

E20.1

ICD-10 Finland

Pseudohypoparathyroidism

130.7

12.4

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

130.7

12.4

R4110

NOMESCO Finland

Physiotherapy

1.5

12.4

485

3482

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

5.6

12.4

C07AG02

ATC

carvedilol; oral

2.2

12.3

121

558

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

12.3

171

912

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

12.3

159

826

WW300

NOMESCO Finland

Transfer of autologic stem cells

9.7

12.2

WF004

NOMESCO Finland

Palliative radiotherapy

3.5

12.2

158

C09CA01

ATC

losartan; oral

1.5

12.1

448

3178

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

12.1

131

631

K65.0

ICD-10 Finland

Acute peritonitis

4.9

12.0

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

21.4

12.0

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

8.7

12.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

7.3

12.0

KBV10

NOMESCO Finland

Removal of stent from ureter

7.6

11.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

11.8

132

645

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

14.7

11.8

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

11.8

181

1003

A07AA02

ATC

nystatin; oral

2.1

11.8

131

637

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

11.8

134

661

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

11.8

342

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

9.0

11.7

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

11.7

174

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

11.7

321

2117

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

11.7

279

1774

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

30.2

11.6

BB1AN

NOMESCO Finland

Parathyroid gland isotope imaging, 1 isotope

65.3

11.6

L04AA01

ATC

[U] ciclosporin; systemic

4.3

11.5

100

C10AA04

ATC

fluvastatin; oral

2.0

11.5

151

786

E83.9

ICD-10 Finland

Disorder of mineral metabolism, unspecified

+∞

11.5

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.4

11.4

411

E66.8

ICD-10 Finland

Other obesity

2.5

11.4

365

C09AA05

ATC

ramipril; oral

1.5

11.4

421

2979

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

11.3

332

2224

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

5.4

11.3

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.2

11.3

190

M54.5

ICD-10 Finland

Low back pain

1.4

11.3

572

4322

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

35.2

11.3

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

11.3

151

794

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

11.3

180

1010

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.7

11.2

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

11.2

316

2099

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

20.1

11.1

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

20.1

11.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.0

11.1

109

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

5.8

11.0

E0000UV

ATC

1.4

11.0

718

5685

C01DA14

ATC

isosorbide mononitrate; oral

1.7

11.0

239

1479

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.7

10.9

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.6

10.9

136

XKD00

NOMESCO Finland

Uroflowmetry

1.6

10.8

284

1849

A02BC03

ATC

lansoprazole; oral

1.4

10.8

549

4145

SPAT1281

SPAT

Other administrative function

1.9

10.8

148

787

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.7

10.8

288

SPAT1097

SPAT

Recording of ECG

1.6

10.8

273

1763

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.3

10.8

164

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

10.7

143

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

10.7

355

2446

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.0

10.7

206

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

17.9

10.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

10.7

904

7467

WX704

NOMESCO Finland

Intubation

2.0

10.7

132

671

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

10.6

405

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

10.6

248

1564

N18

ICD-10 Finland

Chronic kidney disease

5.7

10.6

S97

ICPC

Chronic ulcer skin

2.2

10.5

104

483

R31

ICD-10 Finland

Unspecified haematuria

1.8

10.5

181

1041

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

10.5

125

629

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

7.3

10.5

L04AX01

ATC

azathioprine; systemic

2.4

10.5

391

E31.00

ICD-10 Finland

APECED syndrome

+∞

10.4

L03AA13

ATC

pegfilgrastim; parenteral

2.4

10.4

364

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.7

10.4

121

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

16.1

10.3

F10.24

ICD-10 Finland

Alcohol depence active use

5.0

10.3

C08DB01

ATC

diltiazem; oral

2.2

10.3

105

494

JAH00

NOMESCO Finland

Laparotomy

3.0

10.3

201

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

10.3

110

529

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.6

10.3

303

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.6

10.3

127

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.9

10.3

107

SPAT1104

SPAT

Monitoring of emergency patient

2.0

10.3

127

648

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

18.9

10.3

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

10.2

388

2757

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

10.2

133

692

L01XE04

ATC

[U] sunitinib; oral

13.2

10.2

R33

ICD-10 Finland

Retention of urine

1.9

10.1

139

740

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.5

10.1

134

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

10.1

459

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

10.1

212

A02BA02

ATC

ranitidine; systemic

1.5

10.0

372

2628

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

10.0

149

816

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

5.1

10.0

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.8

10.0

237

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

10.0

287

1910

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

40.2

10.0

ZXA05

NOMESCO Finland

Left side

1.4

10.0

469

3481

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

9.9

152

840

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.0

9.9

181

3012

Kela drug reimbursment

Cabozantinib

16.8

9.9

1502

Kela drug reimbursment

Cabozantinib

16.8

9.9

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.1

9.9

KBV00

NOMESCO Finland

Insertion of stent into ureter

6.3

9.8

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.6

9.8

122

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

9.8

258

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.9

9.8

199

R55

ICD-10 Finland

Syncope and collapse

1.7

9.7

190

1138

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.7

9.7

113

K20

ICD-10 Finland

Oesophagitis

3.8

9.7

103

G72.8

ICD-10 Finland

Other specified myopathies

3.8

9.7

103

R07.3

ICD-10 Finland

Other chest pain

1.8

9.7

167

962

ZXA00

NOMESCO Finland

Right side

1.4

9.7

498

3759

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.2

9.7

H05BX02

ATC

paricalcitol; systemic

55.2

9.6

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

9.6

319

2194

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

9.6

162

B37.08

ICD-10 Finland

Other candidal stomatitis

6.8

9.6

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

9.6

100

477

M10.0

ICD-10 Finland

Idiopathic gout

2.8

9.6

225

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

4.6

9.6

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

9.6

300

2040

SPAT1211

SPAT

Application of soft bandage

1.8

9.5

174

1019

M10.3

ICD-10 Finland

Gout due to impairment of renal function

9.1

9.5

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

10.1

9.5

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

5.7

9.5

JN4CD

NOMESCO Finland

Very extensive body CT

2.3

9.5

364

XG466

NOMESCO Finland

Sleep oxymetry

2.7

9.4

228

R60.0

ICD-10 Finland

Localized oedema

1.7

9.4

200

1227

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

100.4

9.4

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

3.1

9.4

159

M81.8

ICD-10 Finland

Other osteoporosis

5.0

9.4

EP1DS

NOMESCO Finland

PET-MRI of neck metabolism

30.1

9.4

SPAT1172

SPAT

Guidance concerning hydration

3.0

9.4

186

BBA99

NOMESCO Finland

Other operations on parathyroid gland

+∞

9.4

2754B

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCURIA]

+∞

9.4

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

9.4

378

N06AX21

ATC

duloxetine; oral

1.7

9.4

181

1079

K06.18

ICD-10 Finland

Another gingival hyperplasia

12.4

9.4

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

21.8

9.3

SPAT1260

SPAT

Consultation of another employee

1.5

9.3

321

2230

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

9.3

321

2230

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.6

9.3

248

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

9.3

210

1315

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.4

9.2

T99

ICPC

Endocr/metab/nutrit disease other

3.8

9.2

B81

ICPC

Anaemia vit B12/folate deficiency

2.3

9.2

344

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

9.2

287

K92.0

ICD-10 Finland

Haematemesis

2.9

9.2

184

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.5

9.1

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.6

9.1

114

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

7.8

9.1

J01CA04

ATC

amoxicillin; systemic

1.4

9.1

1516

13759

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

9.1

426

3153

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

9.1

371

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

5.6

9.0

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

9.0

122

647

7151

FHL

Kidney transplantation

36.8

9.0

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

36.8

9.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

9.0

150

853

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

9.0

463

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

9.0

374

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.4

9.0

126

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

9.0

111

567

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.1

9.0

478

KA3EB

NOMESCO Finland

Antegrade pyelography

7.5

8.9

394

Kela drug reimbursment

Palbociclib

7.5

8.9

Z71.8

ICD-10 Finland

Other specified counselling

1.5

8.9

394

2882

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

8.8

170

1015

XF402

NOMESCO Finland

ECG with work load test

1.7

8.8

178

1076

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

8.6

8.8

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.3

8.8

363

R80

ICD-10 Finland

Isolated proteinuria

6.3

8.8

H3603, E103

ICD-10 Finland

5.9

8.7

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.9

8.7

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

8.7

554

4330

I50

ICD-10 Finland

Heart failure

2.8

8.7

202

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.8

8.7

192

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

50.2

8.7

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

8.7

151

874

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

8.7

234

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

8.7

829

6910

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

8.7

102

512

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

8.7

252

1501

Kela drug reimbursment

Palbociclib

6.6

8.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

8.6

328

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

8.6

191

1186

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

8.6

463

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.7

8.6

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

6.9

8.5

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.0

8.5

154

SPAT1240

SPAT

Therapeutic discussion

1.7

8.5

158

934

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

8.5

764

6306

N20.2

ICD-10 Finland

Calculus of kidney with calculus of ureter

7.4

8.4

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

8.4

301

2106

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

8.4

125

686

N05CD07

ATC

temazepam; oral

1.6

8.4

223

1453

E85.9

ICD-10 Finland

Amyloidosis, unspecified

90.4

8.4

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.4

8.4

117

M79.6

ICD-10 Finland

Pain in limb

1.4

8.4

619

4949

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

8.4

308

N06AB04

ATC

citalopram; systemic

1.4

8.4

382

2809

G47.3

ICD-10 Finland

Sleep apnoea

1.5

8.4

341

2450

R51.80

ICD-10 Finland

Headache

1.6

8.4

227

1487

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

8.4

106

546

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.5

8.4

262

K65.9

ICD-10 Finland

Peritonitis, unspecified

12.8

8.4

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.3

8.4

341

KAS40

NOMESCO Finland

Excision of transplanted kidney

+∞

8.3

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

8.3

177

1089

N03AX09

ATC

lamotrigine; oral

2.3

8.3

322

J01EA01

ATC

trimethoprim; systemic

1.4

8.3

457

3477

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

8.3

453

3445

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

8.3

311

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

8.2

129

720

C02CA01

ATC

prazosin; oral

3.6

8.2

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.7

8.2

C08CA05

ATC

nifedipine; systemic

1.9

8.2

113

601

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.9

8.2

125

692

G04CA02

ATC

tamsulosin; oral

1.4

8.2

360

2625

M48.0

ICD-10 Finland

Spinal stenosis

1.6

8.2

216

1406

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

8.2

298

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.4

8.1

288

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

4.4

8.1

H25.8

ICD-10 Finland

Other senile cataract

1.6

8.1

203

1302

N05AN01

ATC

lithium; oral

3.0

8.1

154

C09BA02

ATC

enalapril and diuretics; systemic

1.8

8.1

144

840

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

8.1

436

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

11.7

8.1

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

11.7

8.1

105

Kela drug reimbursment

Adrenal cortical hypofunction

11.7

8.1

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

8.1

149

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.9

8.1

N05BA01

ATC

diazepam; systemic, rectal

1.6

8.1

234

1560

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

8.0

164

997

J01DA01

ATC

[U] cefalexin; systemic

1.3

8.0

1146

10073

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.4

8.0

106

192

Kela drug reimbursment

Fulvestrant

5.9

8.0

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

8.0

221

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.9

7.9

3AC01

NOMESCO Finland

4.4

7.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

7.9

117

642

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

7.9

132

755

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.2

7.9

331

EBA00

NOMESCO Finland

Extraction of tooth

1.4

7.9

557

4416

JFF13

NOMESCO Finland

Terminal enterostomy

13.1

7.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

7.9

177

1106

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.3

7.8

113

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.1

7.8

391

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

8.5

7.8

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

7.8

200

1295

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.5

7.8

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

7.8

114

N16.2

ICD-10 Finland

Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism

45.1

7.7

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

15.1

7.7

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.7

7.7

189

A07AA09

ATC

vancomycin; oral

3.5

7.7

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.2

7.6

121

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.4

7.6

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.4

7.6

105

C10AX09

ATC

ezetimibe; oral

1.7

7.6

148

886

R52.9

ICD-10 Finland

Pain, unspecified

1.7

7.6

138

811

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

6.7

7.6

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

25.1

7.6

D07AA02

ATC

hydrocortisone; topical

1.6

7.6

220

1469

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

8.9

7.5

UJF92

NOMESCO Finland

Capsular endoscopy

3.1

7.5

128

N03AX14

ATC

levetiracetam; systemic

2.6

7.5

192

N05AH03

ATC

olanzapine; systemic

2.0

7.5

463

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

3.3

7.5

112

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

7.1

7.5

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

4.8

7.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

7.4

402

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

7.4

954

8230

BB1AQ

NOMESCO Finland

Parathyroidgland SPECT with low dose CT

80.3

7.4

E20

ICD-10 Finland

Hypoparathyroidism

80.3

7.4

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

80.3

7.4

R42

ICD-10 Finland

Dizziness and giddiness

1.4

7.4

370

2763

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

13.4

7.4

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

7.4

231

1569

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.6

7.4

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

7.3

204

1349

NF3AA

NOMESCO Finland

Femur X-ray examination

2.8

7.3

153

YNB10

NOMESCO Finland

Collection of stem cells for transplant

10.9

7.3

F05.9

ICD-10 Finland

Delirium, unspecified

3.2

7.3

109

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.1

7.3

120

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.5

7.3

D86

ICD-10 Finland

Sarcoidosis

9.4

7.3

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

7.3

285

R06AE07

ATC

cetirizine; oral

1.3

7.3

753

6303

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.7

7.3

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

7.2

238

NHQ40

NOMESCO Finland

Amputation of toe

3.2

7.2

115

BB1BN

NOMESCO Finland

Parathyroid gland isotope imaging, 2 isotopes

15.8

7.2

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

15.8

7.2

R4130

NOMESCO Finland

Speech therapy

2.9

7.2

148

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.6

7.2

M81.5

ICD-10 Finland

Idiopathic osteoporosis

4.6

7.2

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

7.3

7.2

M10

ICD-10 Finland

Gout

2.1

7.2

346

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.6

7.2

4CJ01

NOMESCO Finland

30.1

7.1

J01CA08

ATC

pivmecillinam; oral

1.3

7.1

703

5840

E21.4

ICD-10 Finland

Other specified disorders of parathyroid gland

20.1

7.1

SPAT1125

SPAT

Stoma care and guidance

3.2

7.1

111

ZX080

NOMESCO Finland

Image guided radiotherapy

2.8

7.1

150

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

7.1

125

728

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.5

7.1

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.3

7.1

L02BA03

ATC

fulvestrant; parenteral

5.3

7.1

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4.3

7.0

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

4.7

7.0

S18

ICPC

Laceration/cut

1.3

7.0

753

6329

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.9

7.0

R02

ICPC

Shortness of breath/dyspnoea

1.6

7.0

200

1330

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.0

7.0

130

SPAT1252

SPAT

Overall medication plan or its review

1.7

6.9

125

736

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

13.8

6.9

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

13.8

6.9

N06AB10

ATC

escitalopram; oral

1.4

6.9

302

2198

C10AB05

ATC

fenofibrate; oral

3.6

6.9

GBB00

NOMESCO Finland

Tracheostomy

3.8

6.9

N06AA09

ATC

amitriptyline; systemic

1.6

6.8

179

1165

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

8.3

6.8

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.4

6.8

235

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

6.8

115

661

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

6.8

117

678

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

4.2

6.8

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

11.0

6.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

6.8

134

808

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

6.8

163

1037

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.3

6.8

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

40.2

6.8

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

6.8

289

I20.00

ICD-10 Finland

Unstable angina

2.7

6.8

167

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

5.7

6.8

TAB00

NOMESCO Finland

Lumbar puncture

2.1

6.8

371

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

6.7

140

854

R79.0

ICD-10 Finland

Abnormal level of blood mineral

16.7

6.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.3

6.7

249

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

6.7

290

H02AA02

ATC

fludrocortisone; oral

4.3

6.7

B01AF02

ATC

apixaban; oral

1.6

6.7

156

986

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

6.7

271

158

Kela drug reimbursment

Everolimus

22.6

6.7

L01XE26

ATC

[U] cabozantinib; oral

22.6

6.7

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

22.6

6.7

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.9

6.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.9

6.7

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

3.8

6.7

ED1AA

NOMESCO Finland

Mandipular X-ray examination

4.9

6.7

SPAT1153

SPAT

Removal of sutures

1.3

6.7

576

4692

J05AB11

ATC

valaciclovir; oral

1.5

6.7

220

1514

A10AE06

ATC

insulin degludec; parenteral

2.6

6.7

176

SPAT1312

SPAT

General health counselling

1.3

6.6

556

4506

C02EA02

ATC

2.0

6.6

407

L01CA04

ATC

vinorelbine; systemic

4.0

6.6

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

3.1

6.6

107

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

6.6

540

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

6.6

525

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

8.7

6.5

N03AE01

ATC

clonazepam; systemic

1.8

6.5

545

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

6.5

390

C09CA06

ATC

candesartan; oral

1.4

6.5

347

2623

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.8

6.5

136

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.1

6.5

103

T89

ICPC

Diabetes insulin dependent

2.3

6.5

241

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

6.4

237

1668

2521A

ICD-9 Finland

Disorders of parathyroid gland, Hypoparathyroidism

70.0

6.4

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

70.0

6.4

8010/3-C75.0

ICD-O-3

Carcinoma, NOS, of parathyroid gland

70.0

6.4

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

6.4

264

1899

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.4

6.4

5BA08

NOMESCO Finland

4.7

6.4

H35.4

ICD-10 Finland

Peripheral retinal degeneration

4.7

6.4

KAC10

NOMESCO Finland

Total nephrectomy with capsule

4.1

6.4

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.5

6.4

J94.8

ICD-10 Finland

Other specified pleural conditions

3.3

6.4

C09CA03

ATC

valsartan; oral

1.6

6.4

148

935

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.9

6.4

A10BX07

ATC

[U] liraglutide; parenteral

3.8

6.4

R41.0

ICD-10 Finland

Disorientation, unspecified

2.3

6.3

225

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

8.2

6.3

R52.2

ICD-10 Finland

Other chronic pain

2.3

6.3

257

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

6.3

136

839

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

6.3

461

A10BH02

ATC

vildagliptin; oral

2.8

6.3

133

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

6.3

670

5610

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

18.1

6.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

6.3

428

3365

L17

ICPC

Foot/toe symptom/complaint

1.3

6.3

434

3419

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

+∞

6.3

M821, E8358

ICD-10 Finland

+∞

6.3

E83.8

ICD-10 Finland

Other disorders of mineral metabolism

+∞

6.3

E87.3

ICD-10 Finland

Alkalosis

+∞

6.3

R63.4

ICD-10 Finland

Abnormal weight loss

2.1

6.2

306

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.4

6.2

UDC00

NOMESCO Finland

Ear microscopy

1.7

6.2

122

735

L04AA05

ATC

[U] tacrolimus; systemic

26.7

6.2

M821, E2109

ICD-10 Finland

26.7

6.2

ZSB00

NOMESCO Finland

Procedure related to previous procedure classified in chapter B

26.7

6.2

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.8

6.2

134

SPAT1325

SPAT

Vaccination

1.3

6.2

633

5263

L03

ICPC

Low back symptom/complaint

1.4

6.2

399

3103

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

6.2

180

1204

C09DA01

ATC

losartan and diuretics; oral

1.6

6.2

175

1159

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

6.2

619

5135

WF099

NOMESCO Finland

Other radiotherapy

5.0

6.2

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

6.2

100

567

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

6.1

214

N07BB01

ATC

disulfiram; oral

2.1

6.1

300

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

6.1

504

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

7.7

6.1

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.2

6.1

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.1

6.1

102

A06AC51

ATC

ispaghula, combinations; systemic

1.9

6.1

461

KH1EE

NOMESCO Finland

Urologic ultrasound examination

12.5

6.1

N28.1

ICD-10 Finland

Cyst of kidney

3.1

6.1

K90

ICPC

Stroke/cerebrovascular accident

2.5

6.1

171

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

8.6

6.1

C09DB01

ATC

valsartan and amlodipine; oral

2.2

6.0

249

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.9

6.0

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

6.7

6.0

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

6.7

6.0

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

6.7

6.0

R03AC02

ATC

salbutamol; inhalant

1.3

6.0

897

7810

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.6

6.0

155

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018418) pH of Serum or Plasma

1400

5512

4.78

309.56

16.9

3.5

7.4

1.06

357

1072

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1385

2133

14.26

307.65

10.7

4.9

1.0

mmol/l

0.47

1315

1970

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1211

2741

8.01

307.65

6.5

3.2

0.8

mmol/l

19.40

1147

2544

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1332

1306

22.07

307.65

6.2

3.3

83.7

86.4

ng/l

0.28

1144

1108

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

347

295

13.61

307.65

4.2

2.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1760

7777

5.94

307.65

4.4

2.1

76.3

79.2

nmol/l

3.10

1660

6874

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2040

9411

9.52

307.65

25.5

5.7

1.2

mmol/l

12.81

1740

7900

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1868

8546

6.65

307.65

20.9

5.1

1.2

mmol/l

11.87

1782

7668

(3020779) Urea [Moles/volume] in Serum or Plasma

658

1406

6.10

306.95

14.7

6.2

12.6

9.4

mmol/l

20.17

633

1341

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

395

521

8.90

289.65

4.8

3.3

3.8

2.0

ratio

0.34

(3034860) Kappa light chains.free [Mass/volume] in Serum

401

540

8.74

289.04

4.9

3.3

63.4

64.5

mg/l

0.02

313

439

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

398

538

8.69

285.86

4.9

3.3

84.4

51.5

mg/l

0.44

310

441

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

439

733

7.13

260.34

3.2

1.9

41.7

39.4

u/l

1.05

383

651

(3004588) Protein electrophoresis panel - Serum or Plasma

573

1251

5.73

257.85

3.8

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1452

6544

4.16

250.76

5.9

3.4

2.4

mmol/l

2.40

1305

5657

(40760888) Immunoglobulin light chains.free panel - Serum

324

404

9.13

247.48

4.7

3.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

610

1508

5.10

236.41

4.0

2.5

65.1

66.6

g/l

3.87

546

1380

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

202

135

16.27

232.22

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

333

470

8.08

228.97

3.0

1.9

13.8

11.3

mg/l

3.25

297

432

(3024561) Albumin [Mass/volume] in Serum or Plasma

1593

7991

4.05

227.45

10.0

4.4

33.7

35.6

g/l

27.68

1504

7369

(3012544) pH of Venous blood

579

1596

4.48

192.71

8.8

3.4

7.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

555

1481

4.59

192.64

2.4

2.2

376.2

364.8

nmol/l

0.57

518

1352

(3021447) Carbon dioxide [Partial pressure] in Venous blood

570

1564

4.48

190.70

9.0

3.4

5.9

5.8

kpa

0.43

558

1514

(3002032) Base excess in Venous blood by calculation

563

1556

4.44

186.24

9.1

3.4

2.4

2.1

mmol/l

0.96

482

1244

(3036603) Volume of Urine

150

16.79

176.80

2.1

1.3

1968.7

1785.3

0.36

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

636

2025

3.93

171.95

5.1

4.3

260.2

247.8

u/l

0.90

603

1924

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

679

2318

3.71

164.91

4.9

2.3

22.0

22.9

0.89

581

1995

(3022948) Iron [Moles/volume] in Serum or Plasma

746

2711

3.56

164.54

4.7

2.2

11.5

13.2

umol/l

8.52

692

2521

(3004789) Transferrin [Mass/volume] in Serum or Plasma

705

2485

3.62

162.83

4.8

2.2

2.3

g/l

8.66

662

2300

(3023368) Bacteria identified in Blood by Culture

1066

4899

3.14

158.01

7.6

4.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

403

1002

4.64

150.77

4.4

3.0

4.4

4.5

pmol/l

0.31

361

873

(3009343) pH of Capillary blood

421

1084

4.51

150.64

6.1

3.6

7.4

0.93

128

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

423

1101

4.46

149.18

6.2

3.5

5.1

5.2

kpa

1.14

400

1024

(3012565) Volume of 24 hour Urine

116

19.62

148.12

3.1

2.7

2145.9

2016.5

0.34

109

(3037756) Immunofixation for Serum or Plasma

241

383

6.89

147.21

2.5

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

409

1048

4.51

147.09

6.1

3.5

1.9

1.8

mmol/l

0.17

311

789

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1612

9756

3.05

138.71

10.4

5.9

10.7

11.4

umol/l

1.08

1549

9233

(3000991) Gas panel - Venous blood

472

1401

3.96

138.67

11.6

7.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

109

17.53

132.07

7.2

7.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

417

1195

4.02

128.12

2.3

1.6

—

(3013115) Eosinophils [#/volume] in Blood

1576

9655

2.90

128.10

8.7

5.8

0.2

e9/l

0.21

1426

8438

(3006315) Basophils [#/volume] in Blood

1539

9338

2.86

126.95

8.3

5.6

0.0

e9/l

0.01

1387

8040

(3026493) Urate [Moles/volume] in Serum or Plasma

980

4723

2.84

126.92

4.9

2.6

1213.8

5488.4

umol/l

5.55

877

4049

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2062

14808

4.07

125.03

15.3

7.0

89.6

78.3

u/l

12.28

2006

13834

(3001604) Monocytes [#/volume] in Blood

1526

9297

2.81

123.45

8.4

5.6

0.6

e9/l

3.90

1378

7995

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1112

5799

2.73

122.38

3.7

2.3

57.5

58.2

u/l

0.16

1052

5314

(42870588) Differential panel, method unspecified - Blood

1175

6310

2.71

121.78

8.5

5.7

—

(3006504) Eosinophils/100 leukocytes in Blood

1452

8712

2.73

119.55

8.9

5.8

2.6

2.9

4.74

1372

8076

(3019069) Monocytes/100 leukocytes in Blood

1457

8764

2.73

119.24

9.2

6.1

8.7

0.07

1381

8160

(3013826) Glucose [Moles/volume] in Serum or Plasma

1683

10904

2.89

118.67

9.5

4.0

6.8

6.6

mmol/l

1.71

1631

10140

(3022096) Basophils/100 leukocytes in Blood

1421

8456

2.71

118.61

9.0

5.9

0.6

0.7

2.52

1341

7852

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

299

705

4.71

118.36

4.1

2.2

7.5

7.4

g/l

0.34

207

544

(3005719) IgG [Mass/volume] in Serum or Plasma

429

1321

3.75

118.30

3.8

2.9

10.3

10.6

g/l

0.55

391

1205

(3019198) Lymphocytes [#/volume] in Blood

1540

9564

2.75

117.48

8.6

5.6

1.8

1.9

e9/l

3.15

1408

8385

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

298

705

4.69

117.45

4.1

2.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

429

1331

3.72

116.90

7.1

2.9

4.8

4.6

kpa

0.81

416

1288

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

704

4.68

116.75

4.1

2.2

3.9

3.8

g/l

0.28

201

516

(3002030) Lymphocytes/100 leukocytes in Blood

1470

8981

2.68

114.86

9.1

5.9

24.6

28.1

25.10

1382

8314

(3013650) Neutrophils [#/volume] in Blood by Automated count

1677

10950

2.83

114.48

15.2

8.7

4.5

4.0

e9/l

9.58

1536

9520

(21494890) Protein electrophoresis panel - 24 hour Urine

146

175

8.83

113.59

3.2

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

660

4.74

113.40

4.1

2.2

9.6

10.4

g/l

1.74

225

562

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

311

784

4.42

112.93

8.4

4.0

24.3

24.2

mmol/l

0.25

282

698

(3027945) Reticulocytes/100 erythrocytes in Blood

551

2046

3.21

112.56

3.8

2.6

1.9

1.7

3.57

497

1823

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

303

758

4.44

111.06

2.1

1.8

1.7

1.5

g/l

2.36

263

645

(3028026) IgM [Mass/volume] in Serum or Plasma

357

1018

3.95

109.57

2.6

1.9

1.2

1.5

g/l

1.83

317

919

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

123

10.49

109.57

6.3

4.4

94.3

44.6

u/ml

0.37

(3032080) INR in Blood by Coagulation assay

1285

7482

2.57

108.90

10.9

8.3

1.2

1.3

inr

2.57

408

2109

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

464

1584

3.40

108.55

15.1

3.1

1.2

mmol/l

0.57

436

1366

(1616796) Gas panel - Central venous blood

201

361

5.99

108.12

5.3

3.7

—

(3023520) Reticulocytes [#/volume] in Blood

452

1522

3.44

108.05

3.7

2.7

69.6

68.4

e9/l

0.24

371

1142

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

277

665

4.59

106.87

4.2

2.2

3.1

g/l

0.26

203

530

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

921

4634

2.62

105.28

2.7

2.1

3.3

3.1

mg/l

2.10

804

3957

(3018010) Neutrophils/100 leukocytes in Blood

1424

8853

2.53

102.61

8.5

5.7

59.9

57.0

14.62

1352

8237

(3022313) Gas panel - Capillary blood

298

811

4.06

97.15

6.2

3.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

178

315

6.03

97.06

7.6

4.6

435.2

274.2

iu/ml

0.73

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

217

464

5.05

96.10

1.6

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

655

2913

2.73

94.44

2.4

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

251

613

4.46

94.42

4.2

2.2

1.0

1.2

g/l

0.21

198

535

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

754

3598

2.61

94.27

4.8

3.1

2.5

mmol/l

9.12

661

3172

(3044640) Blood type and Crossmatch panel - Blood

1054

5874

2.43

94.22

3.6

2.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

209

443

5.08

93.46

5.5

4.2

2.0

1.4

mg/l

11.35

191

409

(3026782) Osmolality of Urine

739

3512

2.61

92.98

4.3

2.5

503.5

553.1

mosm/kgh2o

8.53

665

2952

(3015235) Bicarbonate [Moles/volume] in Capillary blood

197

400

5.28

92.53

4.9

2.8

24.2

25.2

mmol/l

1.73

183

342

(3014576) Chloride [Moles/volume] in Serum or Plasma

538

2184

2.89

92.11

9.7

6.1

103.7

104.5

mmol/l

2.40

528

2143

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

259

663

4.26

91.56

2.8

2.0

2.9

2.3

ug/l

0.18

232

589

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

986

5394

2.42

91.14

2.6

2.0

216.5

219.7

u/l

0.03

939

5032

(3004119) Hemoglobin [Mass/volume] in Venous blood

329

1015

3.60

89.16

7.7

2.8

118.4

129.1

g/l

13.94

323

988

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1258

7703

2.35

89.15

4.6

2.6

247.2

127.5

ug/l

9.76

1175

7066

(3002582) Erythrocytes [#/volume] in Urine

998

5542

2.39

88.55

5.3

2.9

53.5

92.5

e6/l

1.20

838

4221

(3027273) Bicarbonate [Moles/volume] in Venous blood

288

818

3.87

88.12

8.8

2.7

25.6

25.5

mmol/l

0.18

282

792

(3019309) Folate [Moles/volume] in Red Blood Cells

726

3545

2.51

85.10

2.0

1.7

1293.4

1162.8

nmol/l

2.43

567

2647

(3026008) Bacteria identified in Urine by Culture

1014

5773

2.32

83.75

4.3

3.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1356

8752

2.29

82.44

6.0

3.8

—

(3017704) Immunofixation for Urine

10.25

80.27

1.8

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

159

302

5.57

80.25

3.5

3.8

1.2

1.3

0.23

130

234

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

217

537

4.35

79.94

4.2

2.1

0.0

g/l

0.83

183

496

(3023183) Ammonium ion [Moles/volume] in Plasma

161

311

5.48

79.78

3.8

2.6

34.7

36.0

umol/l

0.23

129

264

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

223

565

4.25

79.64

4.1

2.0

36.2

37.7

g/l

2.24

181

488

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

318

1031

3.41

79.38

8.9

6.9

24.8

25.1

mmol/l

0.63

313

1026

(3037121) Protein [Mass/volume] in Urine

240

645

4.03

79.12

4.1

3.0

0.5

0.2

g/l

2.99

121

249

(3021901) Oxygen saturation in Capillary blood

154

289

5.63

78.73

3.8

2.5

—

(3000850) Epithelial cells [#/volume] in Urine

760

3903

2.40

78.70

4.2

2.4

5.3

5.8

e6/l

0.60

700

3390

(3018095) Leukocytes [#/volume] in Urine

1091

6528

2.25

78.59

6.0

3.3

138.0

125.1

e6/l

0.18

876

4572

(3028626) Oxygen [Partial pressure] in Capillary blood

182

397

4.88

78.45

4.6

3.3

8.2

8.3

kpa

0.31

173

368

(3017181) Myelocytes/100 leukocytes in Blood

411

1566

2.97

77.98

5.3

4.1

0.9

0.30

208

428

(3013707) Erythrocyte sedimentation rate by Westergren method

1886

14223

2.61

77.36

6.3

4.0

18.6

12.3

mm/h

31.65

1780

13107

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

138

238

6.10

77.06

4.2

3.3

492.9

1777.3

u/ml

0.71

(3037467) Urinalysis macro (dipstick) panel - Urine

1776

13077

2.44

75.96

7.2

4.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

571

2609

2.57

75.92

2.5

2.1

29.6

29.8

0.34

549

2520

(3026250) Tacrolimus [Mass/volume] in Blood

14.26

74.31

43.7

28.7

7.1

6.8

ug/l

0.34

(3030467) Casts [#/volume] in Urine by Automated count

910

5145

2.25

74.28

4.8

2.9

0.6

0.4

e6/l

1.35

745

3873

(3007164) IgA [Mass/volume] in Serum or Plasma

692

3488

2.39

74.04

2.3

1.4

2.7

2.5

g/l

0.83

461

2052

(3021440) Promyelocytes/100 leukocytes in Blood

392

1496

2.94

73.90

5.4

4.2

0.1

0.33

202

396

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1134

7014

2.19

73.81

5.4

3.2

44.8

120.1

ng/l

0.60

918

4851

(3014111) Lactate [Moles/volume] in Serum or Plasma

391

1494

2.94

73.53

9.6

5.9

1.5

1.3

mmol/l

0.84

376

1447

(3016502) Oxygen saturation in Arterial blood

424

1707

2.81

72.26

8.4

6.8

94.7

95.7

1.58

410

1645

(3031040) Bacteria [#/volume] in Urine by Automated count

1712

12568

2.31

71.07

6.8

4.3

465.3

1991.9

e6/l

1.45

154

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

199

505

4.21

70.75

4.3

2.1

0.0

g/l

0.00

165

467

(3019225) pH of Specimen

473

2040

2.65

70.28

16.0

3.8

—

(3003396) Base excess in Arterial blood by calculation

457

1940

2.68

70.08

8.1

6.4

1.1

1.2

mmol/l

0.16

379

1490

(3002179) Metamyelocytes/100 leukocytes in Blood

376

1442

2.91

70.02

5.2

4.0

0.7

0.5

0.63

165

315

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

205

540

4.06

69.27

3.8

3.0

0.3

0.4

u/ml

0.93

113

306

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

15.25

69.21

1.7

1.4

0.4

ug/l

0.22

(3027801) Oxygen [Partial pressure] in Arterial blood

454

1947

2.65

68.05

8.2

6.4

11.5

12.4

kpa

3.30

439

1851

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

454

1947

2.65

68.05

8.2

6.4

5.1

kpa

0.50

438

1850

(3010421) pH of Blood

188

472

4.24

67.74

6.9

3.7

7.4

0.07

161

386

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

242

727

3.59

67.63

6.8

3.8

25.0

24.9

mmol/l

0.14

230

682

(3009445) Proteinase 3 Ab [Units/volume] in Serum

242

729

3.58

67.34

1.3

1.5

2.9

27.0

u/ml

—

(3007853) Bacteria identified in Skin by Aerobe culture

475

2099

2.58

66.87

2.1

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

193

499

4.12

66.85

4.4

2.1

0.0

g/l

0.00

165

466

(36304419) Bacteria [Presence] in Urine

872

5013

2.17

66.68

4.6

2.9

—

(3009508) Creatinine [Moles/volume] in Urine

951

5668

2.13

66.11

4.4

3.0

6.5

7.5

mmol/l

10.29

839

4738

(40768446) Kidney Pathology biopsy report

12.58

66.01

1.9

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

907

5326

2.14

65.38

3.7

2.8

3036.0

1271.9

ng/l

5.31

798

4527

(3047189) Immunofixation for 24 hour Urine

9.46

65.07

3.2

1.5

—

(3042936) Bacteria identified in Isolate by Culture

538

2555

2.43

64.68

2.8

1.9

—

(3027315) Oxygen [Partial pressure] in Blood

166

395

4.44

64.09

6.3

4.0

8.7

8.4

kpa

1.29

161

390

(3012501) Base excess in Blood by calculation

165

391

4.46

64.04

6.2

3.9

3.1

2.8

mmol/l

0.73

129

273

(3013290) Carbon dioxide [Partial pressure] in Blood

165

392

4.45

63.83

6.3

3.9

5.1

kpa

0.05

160

387

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

805

4550

2.17

63.69

3.5

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

411

1734

2.66

63.33

3.1

2.1

0.2

g/l

2.78

381

1629

(3025159) Blasts/100 leukocytes in Blood

360

1425

2.80

62.80

5.2

4.2

0.0

0.6

1.01

173

343

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

246

785

3.38

62.45

6.7

2.4

0.7

0.05

240

745

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1190

7827

2.05

62.32

2.5

1.9

95.3

95.6

pmol/l

0.06

648

3948

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

136

7.16

62.06

2.6

1.9

6.4

3.9

mg/l

3.72

129

(3017143) Hepatitis C virus Ab [Presence] in Serum

416

1783

2.62

61.99

2.3

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

156

363

4.53

61.93

3.6

2.2

15.5

16.2

0.91

168

(4035726)

407

1743

2.61

60.66

1.6

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1856

14528

2.29

59.40

6.9

3.9

15.5

14.8

pmol/l

19.61

1730

13079

(3002173) Hemoglobin [Mass/volume] in Arterial blood

378

1582

2.65

58.91

9.1

7.1

114.0

120.6

g/l

6.76

371

1521

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

437

1973

2.49

58.10

2.1

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

169

439

4.07

58.04

1.7

1.6

—

(3044927) Protein electrophoresis panel - Urine

108

193

5.82

58.02

1.3

1.1

—

(3024928) Oxygen saturation in Venous blood

138

314

4.61

56.29

5.4

2.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

277

1021

2.94

54.82

1.8

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

429

1973

2.43

54.51

2.2

1.7

—

(3012516) Albumin [Mass/volume] in Urine

880

5382

2.01

54.49

4.6

3.1

1319.0

296.3

mg/l

3.68

651

3297

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

457

2167

2.37

54.20

2.2

1.6

—

(3003181) Sodium [Moles/volume] in Urine

103

189

5.65

53.79

2.4

1.3

62.0

64.6

mmol/l

0.20

148

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

157

409

4.04

53.66

2.1

1.7

4.4

4.2

iu/l

0.13

126

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

126

277

4.75

53.59

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

24.12

53.08

1.4

—

(3042733) HLA Ab [Presence] in Serum

13.50

52.02

5.6

5.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

913

5735

1.96

51.70

4.4

3.0

33.9

33.2

u/l

0.16

865

5410

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

162

444

3.84

51.55

2.1

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

903

5670

1.96

51.03

5.5

3.8

41.3

6.5

mg/mmol

1.38

660

3446

(3042111) Morphology [Interpretation] in Bone marrow Narrative

133

318

4.37

50.92

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

113

238

4.94

50.56

7.9

6.5

13.5

11.6

mg/l

3.63

223

(3021960) Folate [Moles/volume] in Serum or Plasma

750

4438

2.01

50.12

1.9

1.5

19.9

21.0

nmol/l

0.73

644

3729

(40760892) CBC W Ordered Manual Differential panel - Blood

698

4043

2.03

49.41

6.8

4.4

—

(3019060) Gas panel - Arterial blood

285

1138

2.71

48.28

5.8

4.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

132

327

4.22

48.23

2.1

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

125

298

4.37

48.02

1.6

1.2

281.8

260.8

u/ml

0.31

176

(3037522) Nuclear Ab [Titer] in Serum

472

2378

2.23

47.98

1.5

1.3

485.8

575.6

titre

0.51

510

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

130

320

4.24

47.90

1.6

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

139

6.15

47.62

2.7

2.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

495

2566

2.18

46.75

2.3

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

1280

9177

1.86

46.71

5.4

3.6

0.0

estimate

0.00

334

1697

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

130

329

4.12

46.15

2.1

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

153

435

3.69

46.11

2.1

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

409

1972

2.30

46.06

5.3

3.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

10.62

45.60

3.1

2.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

17.88

45.53

1.5

1.4

122.4

111.8

ng/l

0.08

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

153

5.73

45.28

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

180

5.28

44.78

1.3

1.2

79.2

60.3

u/l

0.82

116

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

160

5.54

44.23

2.5

2.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1552

11936

1.87

44.08

4.8

2.9

71.8

46.9

u/l

9.96

1452

11016

(3033658) Prothrombin time (PT) actual/Normal

747

4579

1.92

43.94

6.6

3.6

91.2

89.9

0.69

726

4463

(3008152) Bicarbonate [Moles/volume] in Arterial blood

264

1063

2.67

43.83

8.3

6.7

24.9

24.6

mmol/l

0.38

251

985

(3009261) Glucose [Presence] in Urine by Test strip

1282

9331

1.82

43.19

5.6

3.6

0.0

estimate

0.15

331

1676

(3021601) Nitrite [Presence] in Urine by Test strip

1268

9201

1.82

43.13

7.3

4.8

0.0

estimate

0.50

331

1722

(3021879) Hepatitis B virus core Ab [Presence] in Serum

276

1145

2.60

43.12

1.6

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

177

582

3.21

42.45

2.4

2.2

421.3

755.1

ug/l

0.45

167

545

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

117

296

4.11

41.53

2.0

1.4

108.0

130.3

u/ml

0.74

(3011985) Renin [Units/volume] in Plasma

186

4.99

41.15

2.6

1.3

30.7

38.4

mu/l

0.46

163

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

174

577

3.18

41.12

1.7

1.6

120.6

227.3

titre

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

202

4.80

41.05

3.3

3.9

63.3

55.1

1.91

134

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

660

3957

1.93

41.01

2.0

1.7

1.4

1.3

mg/l

0.44

510

2999

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

406

2056

2.18

40.14

3.0

4.1

41.9

20.8

ug/l

0.73

343

1660

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

104

248

4.34

39.91

1.8

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

191

687

2.94

39.16

6.3

4.6

1.6

0.48

181

640

(3048929) Epstein Barr virus Ab [Presence] in Serum

152

480

3.32

38.91

1.6

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

507

2844

2.00

37.89

4.4

2.7

3.0

2.7

e6/l

0.30

305

1527

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

665

4085

1.87

37.86

1.8

1.7

475.5

29563344.9

pmol/l

3.13

548

3386

(3035637) Corticotropin [Mass/volume] in Plasma

196

4.68

37.73

1.6

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

546

3.11

37.21

1.4

240.4

289.7

ug/g

2.30

104

325

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

217

859

2.68

37.09

11.2

8.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

16.52

36.67

16.7

8.8

4.7

6.2

mmol/l

1.37

(3006184) Hemoglobin [Mass/volume] in Capillary blood

127

372

3.55

36.55

3.0

2.1

121.4

129.6

g/l

2.44

108

260

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

151

494

3.20

36.46

1.7

1.6

0.2

g/l

0.73

140

472

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

191

716

2.81

36.24

2.3

1.8

—

(3013512) EKG study

853

5712

1.77

36.20

5.1

3.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

174

621

2.95

36.14

2.8

2.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

185

683

2.85

36.12

6.4

4.6

0.9

0.12

177

637

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

130

391

3.46

35.92

1.5

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

226

4.29

35.69

1.2

1.3

0.7

0.6

nmol/l

0.06

217

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

202

791

2.70

35.23

2.7

1.9

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

229

4.23

35.08

1.2

1.3

0.2

0.5

nmol/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

152

512

3.10

34.92

1.7

1.5

1.2

g/l

0.00

142

493

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

14.94

34.83

3.1

2.4

85.3

12.6

mg/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

536

3143

1.91

34.82

3.9

2.6

1.3

1.2

e6/l

0.16

329

1812

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2021

17456

2.09

34.75

8.2

4.6

1.9

mu/l

0.05

1895

15803

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

198

4.47

34.51

1.8

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

126

5.44

34.06

1.3

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

156

4.93

34.04

3.5

2.6

—

(40768797) Stomach Pathology biopsy report

462

2604

1.96

33.64

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2151

19114

2.39

33.21

34.7

12.9

25.4

24.0

mg/l

1.29

1948

14895

(3021589) Normoblasts [#/volume] in Blood

1140

8414

1.69

33.10

19.7

8.9

0.0

e9/l

0.18

972

6860

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

212

877

2.56

33.06

9.6

8.1

23.8

24.5

mmol/l

1.61

198

819

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

141

5.09

32.97

1.8

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

6.12

32.86

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

222

946

2.49

32.50

1.5

1.2

—

(3045142) Bone marrow Pathology biopsy report

222

4.13

32.19

1.5

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

6.00

32.18

1.6

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

635

4024

1.79

31.75

1.3

1.2

1.5

u/ml

0.43

163

1027

(3011412) CD3 cells [#/volume] in Blood

166

4.63

31.61

2.3

2.4

1.0

1.1

e9/l

0.44

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

145

504

3.00

31.53

2.6

1.7

—

(3020891) Body temperature

185

740

2.63

30.86

8.6

4.4

—

(3029937) Albumin [Presence] in Urine by Test strip

754

5059

1.72

30.65

6.0

3.9

0.0

estimate

1.34

304

1665

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

120

5.28

30.55

1.8

1.5

4.0

7.5

u/l

0.78

(3008757) Leukocyte morphology finding [Identifier] in Blood

210

4.11

30.30

3.7

4.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

3.76

30.22

1.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

987

7132

1.66

30.20

5.8

3.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

211

4.09

30.11

1.2

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

372

2020

2.00

29.87

4.6

2.7

8.2

7.8

umol/l

0.14

311

1756

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

202

4.12

29.32

1.3

—

nmol/l

—

(40758558) Short blood count panel - Blood

713

4771

1.71

28.95

10.9

6.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

9.57

28.87

5.4

3.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

325

3.37

28.41

1.7

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

416

2385

1.90

28.35

22.7

25.0

1.4

inr

0.03

348

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

287

3.52

28.21

1.7

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

240

3.77

28.14

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

175

4.27

27.84

1.4

1.3

306.2

270.8

pmol/l

0.32

134

(3024522) Salmonella sp identified in Specimen by Organism specific culture

238

3.76

27.70

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

235

3.76

27.43

1.5

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2194

19957

2.38

27.01

40.4

14.5

139.3

139.8

mmol/l

13.45

2167

19413

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

227

1064

2.25

26.64

2.1

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

116

5.01

26.55

2.3

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2197

20023

2.38

26.45

41.2

14.6

4.0

mmol/l

0.99

2165

19439

(3047181) Lactate [Moles/volume] in Blood

134

493

2.82

26.26

7.6

5.5

1.4

1.2

mmol/l

0.75

122

424

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

135

500

2.80

26.13

1.3

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

130

4.71

25.97

2.4

2.3

73.3

70.3

0.55

124

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

135

504

2.78

25.74

2.9

2.7

3.6

g/l

0.21

127

474

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

252

3.55

25.47

1.7

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

13.46

25.40

6.1

5.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

133

4.60

25.27

1.8

1.3

—

(3000494) Fungus identified in Specimen by Culture

376

2164

1.88

25.09

1.8

1.4

—

(40768804) Tissue Pathology biopsy report

1049

7937

1.58

25.09

2.4

2.1

—

(40761535) Cells panel - Urine sediment

305

1638

1.99

25.02

4.6

3.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

708

4880

1.64

24.96

5.5

3.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

12.02

24.74

1.6

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

128

4.62

24.56

2.4

2.3

16.0

13.3

0.46

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

4.79

24.34

1.7

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

232

3.58

24.13

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

232

3.58

24.13

1.5

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

6.34

24.01

23.5

26.5

93.0

127.1

ug/l

2.23

(3005988) Vibrio sp identified in Specimen by Organism specific culture

233

3.56

23.98

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

5.82

23.69

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

5.82

23.69

1.6

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

281

3.29

23.46

1.3

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.90

23.42

1.1

—

(3024932) HLA-DR beta [Type]

7.09

23.34

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

102

4.99

23.24

1.8

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

103

4.94

22.99

1.8

1.6

—

(3024471) HLA-A [Type]

6.95

22.93

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

170

3.97

22.90

2.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

170

3.97

22.90

2.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

170

3.97

22.90

2.3

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

5.14

22.62

1.1

133.9

77.2

u/l

1.13

(40768441) Liver Pathology biopsy report

121

4.54

22.46

1.6

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

119

447

2.75

22.43

1.2

70.7

103.3

titre

0.78

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

107

383

2.88

22.07

4.9

3.5

61.7

57.4

2.53

107

383

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

8.57

21.90

4.7

3.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

281

1533

1.95

21.90

2.7

2.2

4.9

7.1

ug/l

2.37

234

1350

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.19

21.63

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

4.97

21.35

1.1

79.1

21.6

u/l

1.32

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

218

3.47

21.15

2.2

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

116

4.47

20.83

2.1

2.2

550.2

710.4

e6/l

0.84

(21494815) CD4 cells/100 lymphocytes in Specimen

134

4.18

20.58

2.4

2.3

41.2

42.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

114

4.46

20.37

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

227

1179

2.02

20.31

1.2

180.5

141.4

iu/ml

0.55

423

(3042631) Mycobacterium sp identified in Specimen

262

3.17

19.95

2.4

2.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

9.67

19.68

1.4

1.5

—

(3008295) Osmolality of Serum or Plasma

140

4.00

19.42

1.6

1.5

279.9

283.0

mosm/kgh2o

0.30

102

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

4.75

19.41

2.6

3.0

38.9

39.7

0.06

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

515

3463

1.62

19.29

5.2

3.4

184.7

719.0

ng/l

1.24

430

2708

(3000093) Morphology [Interpretation] in Blood Narrative

155

3.81

19.15

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

131

558

2.43

19.10

1.9

1.6

0.4

11.4

iu/ml

0.48

106

(3043409) Potassium [Moles/volume] in Arterial blood

129

546

2.44

19.08

4.9

4.1

3.9

mmol/l

0.08

120

522

(3025315) Body weight

16.10

18.51

5.0

4.2

—

(3011648) Oxygen content in Venous blood

106

4.41

18.51

3.4

3.6

9.9

11.5

1.65

106

(3014148) Varicella zoster virus Ab [Titer] in Serum

179

3.53

18.30

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

283

1638

1.83

18.24

6.3

3.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

199

3.38

18.23

2.2

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.94

18.05

3.8

3.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

8.59

18.02

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

301

2.89

17.92

1.3

24.5

35.0

u/l

0.80

259

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.88

17.91

2.3

1.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

256

3.03

17.51

1.9

2.2

66.8

1236.9

u/ml

0.58

245

(3009214) Lutropin [Units/volume] in Serum or Plasma

381

2.64

17.31

1.6

1.4

14.8

11.9

u/l

0.71

311

(3039000) Anion gap in Blood

356

2.68

16.94

9.1

6.2

11.7

11.1

mmol/l

0.95

313

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

204

3.25

16.86

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

357

2.67

16.85

9.1

6.2

105.5

mmol/l

0.00

314

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

106

434

2.51

16.85

2.8

3.4

672.6

956.3

u/ml

0.13

401

(3016750) Collection duration of Urine

4.47

16.84

3.8

1.9

502.7

482.7

min

0.59

(3048689) Calprotectin [Mass/mass] in Stool

343

2148

1.70

16.74

2.3

2.1

144.2

137.9

ug/g

0.14

269

1644

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

10.07

16.71

4.3

1.9

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.06

16.68

2.5

1.9

—

(3003694) ABO and Rh group [Type] in Blood

682

5038

1.50

16.39

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

392

2.56

16.35

1.7

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

117

3.99

16.30

2.3

2.5

517.8

494.9

e6/l

0.09

(3004775) Volume in Urine collected for unspecified duration

126

3.87

16.29

3.4

2.2

728.5

638.9

0.69

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

106

442

2.46

16.21

1.8

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.86

16.19

1.5

—

(3014271) Vancomycin [Susceptibility]

4.79

16.13

3.7

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

133

3.74

15.87

1.1

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

108

463

2.40

15.56

1.9

1.5

359.8

299.0

mu/l

1.02

424

(3004451) EKG impression Narrative

5.14

15.53

1.7

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

38.31

15.38

6.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

161

3.41

15.22

1.4

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

293

2.72

14.77

1.4

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.09

14.72

2.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.09

14.72

2.8

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.09

14.72

2.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.09

14.72

2.8

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.37

14.56

1.2

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

6.63

14.48

1.7

1.3

228.1

40.9

mu/l

0.97

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.93

14.42

1.5

3.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1984

18160

1.58

14.41

31.4

12.0

69.9

79.3

ml/min/173m2

42.79

1805

14892

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

148

3.43

14.27

2.1

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

591

4357

1.48

13.97

4.9

3.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

258

1570

1.72

13.88

4.7

2.5

45.5

66.2

ml/min/173m2

13.93

139

606

(21494434) Karyotype in Bone marrow

183

3.11

13.64

1.2

—

(3019977) pH of Arterial blood

4.45

13.55

1.6

2.9

7.4

0.37

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

135

674

2.06

13.44

2.3

3.4

1380.4

1987.5

u/ml

0.13

115

564

(3036489) Thrombin time

130

641

2.09

13.38

2.3

21.4

21.2

0.24

119

563

(3026389) Candida sp identified in Specimen by Organism specific culture

240

2.80

13.32

2.0

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

252

2.75

13.25

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

106

484

2.25

13.24

2.6

2.8

218.5

184.6

2.90

461

(3016650) Hepatitis A virus Ab [Presence] in Serum

241

2.79

13.22

1.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

390

2.39

13.16

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

390

2.39

13.16

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

4.54

13.07

4.3

1.8

2.1

2.0

umol/l

0.37

(40761511) CBC panel - Blood by Automated count

2128

19906

1.69

13.07

32.0

12.3

—

(3022145) Colonoscopy Study observation

322

2108

1.61

13.05

1.4

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

22.66

12.89

1.7

1.5

334.4

400.9

umol/24h

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

383

2.38

12.76

3.8

2.2

160.8

88.7

ug/min

1.01

224

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

154

3.23

12.75

2.0

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

11.88

12.64

1.2

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

9.43

12.55

8.3

4.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

263

1652

1.67

12.55

3.8

2.4

37.2

69.2

u/l

0.57

228

1418

(3017732) Neutrophils [#/volume] in Blood

213

1267

1.75

12.41

3.1

2.9

4.1

e9/l

0.11

145

972

(3048879) Bone marrow aspiration report

4.63

12.12

1.7

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

267

2.59

11.86

1.6

1.7

1.0

0.9

g/l

0.26

201

(40768795) Lymph node Pathology biopsy report

200

2.84

11.72

1.6

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.92

11.55

2.9

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2168

20481

1.71

11.54

19.7

9.9

25.3

25.2

u/l

0.00

2119

19634

(3002256) Pathology report gross observation

364

2524

1.52

11.38

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

416

2.21

10.96

2.2

2.0

3066.1

2885.7

u/l

0.02

163

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

191

2.82

10.93

2.0

1.5

—

1616.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.85

10.93

3.0

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.85

10.93

3.0

1.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

132

709

1.91

10.72

1.4

1.2

0.3

1.3

u/ml

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

287

1913

1.57

10.70

2.0

1.7

1.5

4.32

234

1673

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

238

1518

1.63

10.66

3.8

2.7

262.6

186.0

ng/l

0.91

215

1386

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.58

10.64

1.5

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

214

2.66

10.35

1.4

33.3

29.0

u/l

0.30

179

(3027135) IgG subclass 1 [Mass/volume] in Serum

169

2.88

10.34

1.3

1.4

7.1

7.0

g/l

0.05

116

(3028192) IgG subclass 2 [Mass/volume] in Serum

169

2.88

10.34

1.3

1.4

2.6

2.9

g/l

0.77

117

(3024139) IgG subclass 3 [Mass/volume] in Serum

169

2.88

10.34

1.3

1.4

0.5

0.4

g/l

0.34

115

(4062490)

169

2.88

10.34

1.3

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

5.16

10.31

1.2

456.6

274.3

pmol/l

0.59

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

101

501

2.06

10.29

1.9

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

443

2.12

10.13

1.3

1.4

473.0

525.6

mg/l

0.70

418

(36660697) Celiac disease serology panel - Serum

226

1444

1.62

10.05

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.68

9.98

2.5

2.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

432

3178

1.44

9.94

1.4

1.3

48.2

39.0

iu/ml

0.41

139

995

(3020191) Ethanol [Moles/volume] in Serum or Plasma

115

3.25

9.86

1.7

1.2

promille

0.01

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

343

2.26

9.83

1.9

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

7.41

9.70

2.0

1.4

—

(3019150) Specific gravity of Urine by Refractometry

528

4042

1.39

9.67

5.7

4.0

1.0

kg/l

1.25

576

(44806118)

210

2.61

9.66

1.8

1.5

—

(44790047)

210

2.61

9.66

1.8

1.5

—

(44790048)

210

2.61

9.66

1.8

1.5

—

(44790049)

210

2.61

9.66

1.8

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.51

9.62

1.1

1.3

5.4

6.6

u/l

0.71

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

229

2.53

9.55

1.1

1.7

1.5

g/l

2.68

200

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

388

2.15

9.47

1.2

1.5

3.9

3.7

mmol/l

0.66

365

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

6.19

9.46

1.8

1.5

1.3

1.2

mmol/l

0.70

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

261

2.41

9.41

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

119

3.14

9.34

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

162

2.81

9.34

1.3

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

5.70

9.27

2.1

1.5

1.2

mmol/l

0.60

(3003434) Protein [Mass/volume] in Pleural fluid

247

2.42

9.08

1.5

1.4

32.8

33.3

g/l

0.11

226

(3019832) Treponema pallidum Ab [Presence] in Serum

186

1164

1.65

8.98

1.8

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

410

3039

1.42

8.98

1.3

1.2

9.4

13.6

u/ml

0.79

142

1173

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1250

10949

1.30

8.90

3.3

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

356

2576

1.45

8.88

11.9

6.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

359

2.15

8.83

3.5

1.8

1.1

0.7

nmol/l

2.53

298

(3028433) Virus identified in Specimen by Culture

3.63

8.56

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

206

2.51

8.49

4.3

2.3

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

3.36

8.48

15.3

12.0

0.8

0.6

mmol/l

2.53

(3044889) 12 lead EKG panel

1504

13551

1.30

8.42

4.8

3.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

111

3.09

8.40

1.8

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

168

1045

1.65

8.32

2.7

3.5

65.1

70.1

u/ml

0.09

162

1007

(3023199) Leukocytes [#/volume] in Pleural fluid

224

2.40

8.02

1.4

1574.8

1579.3

e6/l

0.00

163

(3000475) Leukocytes [#/volume] in Synovial fluid

449

1.97

8.01

2.1

1.6

15465.1

14637.5

e6/l

0.06

316

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.54

7.97

3.1

4.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

283

2.22

7.87

1.2

—

(3049717) Cytology report of Urine Cyto stain

124

721

1.76

7.87

2.3

2.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

116

2.96

7.81

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.75

7.64

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

118

2.91

7.59

1.1

1.2

—

(3035880) pH of Pleural fluid

3.12

7.56

1.5

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

3.50

7.54

1.1

1.2

—

4.6

iu/ml

—

(3004616) Nuclear Ab [Presence] in Serum

237

2.31

7.53

1.4

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

377

2.02

7.46

1.4

1.7

400.6

950.2

e6/l

0.56

312

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

377

2.02

7.46

1.3

1.6

18.3

16.5

e6/l

0.04

299

(44816559) Phosphatidylethanol [Mass/volume] in Blood

297

2.15

7.41

1.8

1.4

—

(40765096) Chromosome analysis panel by Banding

3.45

7.39

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

529

1.85

7.29

5.1

3.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.11

7.28

1.2

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

101

567

1.82

7.23

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.69

7.19

1.1

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

6.90

7.15

1.0

1.2

—

mmol/l

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.14

7.14

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

7.72

7.12

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1887

17686

1.33

7.07

7.9

5.4

41.0

39.4

mmol/mol

8.72

1716

16195

(3044242) Glucose [Moles/volume] in Arterial blood

3.23

6.97

1.6

2.6

—

(3023419) Bacteria identified in Sputum by Culture

240

2.24

6.90

2.5

2.6

—

(3044290) Cell count panel - Cerebral spinal fluid

361

2.00

6.87

1.3

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

230

2.24

6.72

1.9

1.6

70.7

57.6

1.64

142

(3052592) Norovirus Ag [Presence] in Stool

5.02

6.70

2.4

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.06

6.62

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.06

6.62

1.2

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

540

1.79

6.56

1.4

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

541

1.79

6.52

1.4

1.1

—

(3000012) Reticulocyte production index

3.02

6.50

1.6

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

154

1000

1.58

6.45

2.7

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.15

6.44

1.3

1.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.94

6.43

1.1

1.0

1.2

u/l

1.83

(42529406) Shigella sp [Presence] in Stool by Culture

544

1.78

6.41

1.4

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.75

6.36

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.36

6.27

1.0

1.1

1479.7

1475.6

miu/ml

0.01

(3000060) B lymphocytes [#/volume] in Blood

3.85

6.26

2.1

2.7

312.2

255.3

e6/l

—

(3001218) Citrate [Mass/time] in 24 hour Urine

+∞

6.25

1.0

0.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.31

6.02

1.5

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.31

6.02

1.5

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.27

5.95

1.2

1.4

—

(4146454)

172

2.35

5.91

3.2

2.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.54

5.88

1.0

1.1

93.3

84.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.92

5.71

1.1

—

(3012441) Differential panel - Pleural fluid

188

2.26

5.68

1.6

1.4

—

(3045788) Cell count panel - Pleural fluid

176

2.29

5.63

1.3

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.41

5.58

2.5

2.2

—

(3007461) Platelets [#/volume] in Blood

2206

21356

1.49

5.58

48.5

19.3

254.0

249.9

e9/l

1.66

2176

20752

(3017569) Oxygen content in Arterial blood

2.95

5.57

1.8

2.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

178

2.27

5.49

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.07

5.49

1.4

1.2

—

(3024731) MCV [Entitic volume]

2206

21363

1.49

5.49

48.3

19.2

91.6

91.2

3.61

2186

21002

(3028308) Erythrocytes [#/volume] in Pleural fluid

204

2.18

5.48

1.3

1.4

10569.9

93460.5

e6/l

1.41

118

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.64

5.48

1.0

1.2

—

(3035941) MCH [Entitic mass]

2206

21365

1.49

5.46

48.3

19.2

30.2

30.3

1.60

2186

21001

(3000034) Microalbumin [Mass/volume] in Urine

141

2.43

5.46

3.7

2.5

174.0

20.4

mg/l

1.06

(3026361) Erythrocytes [#/volume] in Blood

2206

21366

1.49

5.45

48.5

19.3

4.2

4.5

e12/l

61.42

2175

20688

(1761482) Bacteria [#/volume] in Urine by Culture

474

1.76

5.41

5.6

4.5

—

(3010813) Leukocytes [#/volume] in Blood

2206

21370

1.48

5.40

48.6

19.3

7.2

6.7

e9/l

15.85

2174

20679

(3000963) Hemoglobin [Mass/volume] in Blood

2206

21372

1.48

5.38

48.8

19.4

127.1

134.9

g/l

81.77

2186

21009

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1447

0.60

5.35

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

207

2.15

5.30

1.2

1.5

0.3

nmol/l

0.29

161

(3051651) Icteric interference index of Serum or Plasma

102

2.67

5.24

5.7

2.5

—

(3028714) Urate [Moles/time] in 24 hour Urine

+∞

5.21

1.2

0.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.65

5.20

2.0

1.3

12.8

32.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

326

2534

1.33

5.20

5.2

4.2

31.8

32.8

0.74

236

1660

(3006653) Thiamine [Moles/volume] in Blood

2.89

5.19

1.2

118.4

142.7

nmol/l

1.73

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

518

1.71

5.18

1.4

1.2

30.7

40.2

u/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.02

5.17

1.1

1.2

0.7

umol/24h

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.35

5.16

1.0

1.2

108.2

87.8

—

(3002385) Erythrocyte distribution width [Ratio]

1672

15634

1.24

5.15

39.3

15.8

14.3

13.7

40.04

1655

15253

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

103

2.64

5.15

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

159

1096

1.48

5.11

1.4

1.3

146.0

209.1

u/ml

0.77

147

1011

(3008536) Aspergillus sp Ab [Presence] in Serum

3.77

5.09

2.0

1.4

—

(40768806) Pleura Pathology biopsy report

199

2.13

4.99

1.4

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

173

2.22

4.97

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

100

2.62

4.89

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.23

4.89

3.1

215.1

175.2

umol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.65

4.82

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

125

2.42

4.80

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

125

2.42

4.80

1.3

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

278

1.93

4.79

1.2

1.1

25.3

111.4

iu/ml

1.23

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

394

1.77

4.78

1.4

1.2

—

9.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

11.46

4.78

5.6

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

165

1162

1.45

4.77

2.3

2.1

12.0

13.0

nmol/l

0.71

137

1036

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

126

2.40

4.73

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.85

4.65

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

127

2.38

4.65

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

127

2.38

4.65

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

127

2.38

4.65

1.3

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.91

4.60

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

173

2.16

4.57

1.8

1.3

141807.8

21459.0

e6/l

0.60

122

(3020393) Adenovirus Ag [Presence] in Stool

4.78

4.53

1.3

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

10.03

4.52

1.5

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

10.03

4.52

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

249

1.95

4.50

1.3

1.2

2.1

3.8

u/ml

1.65

106

(3024891) Influenza virus A+B Ag [Presence] in Specimen

478

1.68

4.48

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

300

1.85

4.44

1.8

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

124

2.36

4.41

1.3

1.4

17.9

13.1

u/l

1.04

117

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

265

1.91

4.41

3.0

2.3

31.4

25.6

mg/l

0.23

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

962

0.56

4.41

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

106

2.47

4.38

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

106

2.47

4.38

1.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

489

1.66

4.37

1.3

—

(3022621) pH of Urine by Test strip

174

1259

1.41

4.36

4.7

3.0

—

(3032057) Clostridioides difficile [Presence] in Stool

3.51

4.33

1.3

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.67

4.32

1.3

1.2

—

(3044941) Cell count panel - Synovial fluid

305

1.82

4.23

2.1

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

479

1.65

4.20

1.1

—

(40757373) Influenza virus identified in Isolate

3.63

4.20

1.3

—

(3021788) Differential panel - Synovial fluid

353

1.75

4.09

2.0

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

4.36

4.09

8.6

7.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

101

665

1.54

4.08

1.5

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

3.53

4.05

2.8

3.9

105.7

51.5

u/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

556

1.59

4.01

1.8

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.02

4.01

1.4

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1952

18715

1.25

3.98

5.6

4.5

6.1

5.9

mmol/l

7.17

1756

16852

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

118

2.30

3.94

1.2

1.1

—

(4010399)

184

1369

1.37

3.93

1.4

—

(3045424) Erythrocytes [Presence] in Urine

321

1.76

3.89

2.1

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.18

3.89

2.6

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.18

3.89

2.6

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

460

1.63

3.83

1.3

161.7

218.2

miu/ml

0.63

214

(3027456) Digoxin [Moles/volume] in Serum or Plasma

384

1.69

3.80

3.9

3.0

0.8

nmol/l

0.02

289

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.54

3.76

1.0

1.1

65.6

77.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.54

3.76

2.1

3.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.54

3.76

1.1

58.0

66.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

12.03

3.76

1.3

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.92

3.73

1.6

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.58

3.72

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.01

3.70

1.5

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

4.01

3.70

8.6

7.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

482

1.60

3.65

1.4

1.2

1.5

2.7

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

490

1.59

3.64

1.4

1.2

3.3

4.2

u/ml

0.29

(21494755) Public health laboratory ask at order entry panel

100

1447

0.68

3.60

1.2

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.95

3.57

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.95

3.57

2.8

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

234

1.85

3.56

5.6

5.1

335.3

360.8

umol/l

0.47

201

(3034274) Bile acid [Moles/volume] in Serum --fasting

144

2.10

3.53

2.3

5.9

7.2

umol/l

0.25

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.06

3.53

2.5

1.6

4906.3

34168.1

e6/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

257

1.81

3.51

1.2

4.5

3.9

u/ml

0.07

(40758292) HTLV I+II Ab panel - Serum

3.56

3.48

1.6

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

133

2.12

3.39

1.0

1.3

1.6

1.4

nmol/l

0.19

117

(3009542) Hematocrit [Volume Fraction] of Blood

1803

17233

1.19

3.34

31.4

14.1

37.8

39.5

9.25

1113

11891

(3026480) Teichoate Ab [Titer] in Serum

5.73

3.34

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

182

1.94

3.34

1.9

1.4

23.0

32.1

0.96

111

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.75

3.23

1.0

3.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

661

1.47

3.21

1.6

1.4

27.2

30.0

iu/l

0.32

565

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.58

3.19

1.1

1.2

—

(3006270) Folate [Moles/volume] in Blood

137

2.06

3.16

1.1

383.7

379.4

nmol/l

0.03

120

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

138

2.04

3.11

1.1

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

190

1.85

2.97

3.0

4.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.64

2.96

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.10

2.88

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

649

5780

1.17

2.87

4.7

5.0

5.8

4.5

ug/l

0.45

578

5181

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

171

1.88

2.86

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.94

2.86

1.3

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

123

2.04

2.81

3.7

2.2

—

(3028707) Methadone [Presence] in Urine by Screen method

194

1.82

2.80

1.6

1.8

—

(3019174) dRVVT (LA screen)

4.46

2.79

1.4

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.24

2.77

2.5

2.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

8.35

2.75

1.8

1.0

—

(3000330) Specific gravity of Urine by Test strip

127

950

1.36

2.71

5.5

3.4

—

(3002619) Bacteria identified in Specimen by Culture

2.98

2.69

1.5

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

4.22

2.68

1.4

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.76

2.67

12.4

8.1

0.2

0.5

umol/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.76

2.67

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.76

2.67

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.76

2.67

1.4

1.0

—

(4027681)

2.18

2.67

1.6

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

118

878

1.36

2.61

1.5

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

120

2.01

2.61

1.7

1.3

—

66.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.15

2.55

2.6

5.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.43

2.54

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

173

1.80

2.46

1.4

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.68

2.45

2.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.95

2.41

1.1

1.3

—

(4212803)

3.65

2.36

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.15

2.34

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

113

853

1.34

2.31

2.2

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.87

2.30

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.87

2.30

1.0

1.2

—

(3014891) Appearance of Pleural fluid

3.49

2.27

1.5

—

(3020491) Glucose [Moles/volume] in Blood

135

1.86

2.22

2.4

2.0

7.1

6.8

mmol/l

0.19

(3050794) Legionella sp Ab [Presence] in Serum

5.56

2.21

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.42

2.19

1.5

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.42

2.19

1.8

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.69

2.15

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

157

1254

1.27

2.14

1.4

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.30

2.14

1.6

1.7

—

1424630.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

235

1.63

2.14

1.2

1.1

0.7

2.0

u/ml

—

(3051611) Lipemic interference index of Serum or Plasma

190

1.69

2.10

5.5

2.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

292

1.55

2.09

2.2

1.8

191.3

203.8

pmol/l

0.28

277

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

124

1.86

2.07

1.2

1.4

—

81.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

351

1.49

2.03

1.6

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.41

2.02

2.3

2.2

—

(3000492) Spirometry study

206

1715

1.22

1.96

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.36

1.95

1.2

1.3

53.8

575.5

ug/l

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.97

1.93

1.9

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.97

1.93

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.76

1.93

1.0

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.76

1.93

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.12

1.92

1.1

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

220

1.60

1.88

1.4

1.2

—

(3022689) Creatine [Moles/volume] in Urine

2.65

1.86

2.9

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.86

1.86

1.1

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.40

1.85

4.8

8.3

68.3

71.1

—

(4268621)

183

1.65

1.82

1.8

2.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.27

1.80

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.35

1.77

1.4

1.3

—

(3008898) HLA-B27 [Presence]

583

1.35

1.77

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

329

2885

1.16

1.76

1.5

—

(1761868) Lipid panel - Serum or Plasma

578

6321

0.89

1.76

3.4

2.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.45

1.75

1.4

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1853

18013

1.13

1.74

4.8

3.8

1.4

1.3

mmol/l

21.23

1669

16230

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.92

1.72

1.3

1.2

50.6

17.7

u/l

—

(3033799) Differential panel - Peritoneal fluid

2.30

1.70

2.0

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

319

0.56

1.69

1.2

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.16

1.66

8.3

7.9

—

(3016879) Cocaine [Presence] in Urine

420

1.39

1.62

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.58

1.61

1.0

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.33

1.60

1.4

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.07

1.59

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.00

1.58

1.0

1.2

1.7

1.9

umol/24h

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.82

1.57

1.2

1.1

1.0

ratio

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.21

1.57

1.1

—

(3011288) Drugs identified in Urine by Screen method

297

1.46

1.56

1.9

2.0

—

(3000285) Sodium [Moles/volume] in Blood

2.43

1.53

1.1

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.34

1.52

1.0

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

177

1.59

1.51

1.8

2.3

2.8

1.9

u/field

0.50

(3051593) INR in Capillary blood by Coagulation assay

1.87

1.50

2.1

14.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

2.01

1.48

3.0

2.0

51.6

53.4

umol/l

—

(4306422)

243

1.49

1.47

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

1.75

1.46

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.88

1.44

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.04

1.43

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.04

1.43

1.1

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.31

1.43

1.1

—

(4034850)

623

1.29

1.42

14.9

9.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

126

1.67

1.40

1.6

1.3

0.1

1.3

u/ml

0.92

(3013637) Mi-2 Ab [Presence] in Serum

2.20

1.37

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.20

1.37

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.20

1.37

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.20

1.37

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

256

1.45

1.36

1.5

1.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.97

1.32

1.6

1.3

55.8

54.3

0.04

(3032773) Endomysium IgG Ab [Titer] in Serum

152

1.58

1.31

1.1

—

(3025130) Human papilloma virus identified in Specimen

206

0.53

1.29

1.4

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.09

1.27

1.9

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.00

1.27

2.1

1.3

11.8

8.5

ug/l

1.42

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

131

1.61

1.23

1.0

1.4

10.9

12.4

mmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.91

1.22

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.91

1.22

1.0

1.3

0.3

g/l

1.97

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.05

1.22

1.4

1.2

95.6

133.2

nmol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.63

1.21

1.0

1.4

—

(3006462) Nitrate [Presence] in Urine

1.73

1.21

5.4

4.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.31

1.18

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

454

1.31

1.18

1.5

—

(3024263) Appearance of Synovial fluid

1.71

1.17

1.9

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

211

0.57

1.16

1.2

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

198

0.55

1.15

1.4

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.50

1.15

1.4

1.1

—

(3005033) Fetal Nuchal fold Thickness US

210

0.57

1.14

1.2

1.4

—

(3027008) Opiates [Presence] in Urine

457

1.30

1.14

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.34

1.12

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

459

1.29

1.11

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.73

1.09

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

218

0.59

1.07

1.2

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

253

1.39

1.06

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

263

1.37

1.03

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

221

1.41

1.02

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

113

956

1.19

1.02

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.89

1.01

2.9

3.0

34.8

27.9

umol/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.18

0.98

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.18

0.98

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

266

1.36

0.98

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.78

0.94

1.2

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.89

0.94

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

167

1.44

0.92

1.4

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.15

0.91

1.7

1.5

—

(40768443) Skin Pathology biopsy report

103

875

1.19

0.91

1.2

—

(4211845)

102

1.57

0.90

5.4

3.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.61

0.87

1.2

1.4

—

(3027944) Amphetamines [Presence] in Urine

451

1.25

0.85

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1901

18702

1.08

0.84

5.1

4.2

1.4

1.5

mmol/l

14.65

1728

16998

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.88

0.81

1.3

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.61

0.81

1.1

1.0

—

(3003338) MCHC [Mass/volume]

1562

15954

0.94

0.77

41.2

17.0

329.9

332.0

g/l

15.10

1552

15820

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.09

0.74

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.72

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.93

0.70

1.4

2.5

11.4

18.3

umol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

170

0.65

0.70

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.71

0.70

2.4

1.6

—

(40768793) Breast Pathology biopsy report

491

1.21

0.69

1.4

1.3

—

(3020650) Glucose [Presence] in Urine

1.53

0.68

1.1

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1912

18866

1.07

0.65

5.1

4.3

4.5

4.7

mmol/l

11.68

1740

17243

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

0.64

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.60

0.0

5.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.60

0.0

2.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.54

0.59

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.48

0.57

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

160

0.69

0.55

1.1

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.58

0.54

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

226

0.75

0.52

1.2

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1947

19265

1.06

0.50

5.5

4.7

2.6

2.8

mmol/l

12.19

1764

17497

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

258

0.77

0.50

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

258

0.77

0.50

1.2

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

269

0.78

0.50

1.1

1.8

5.1

u/ml

—

143

(3047007) Chlamydophila sp Ab [Presence] in Serum

261

1.23

0.49

1.4

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

476

0.84

0.49

1.2

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

257

0.78

0.49

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

257

0.78

0.49

1.2

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

279

0.79

0.49

1.2

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

199

1.26

0.48

1.2

1.3

7.7

7.5

mmol/l

0.14

145

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

129

1.32

0.45

1.0

890.5

677.6

ng/l

0.75

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

103

1.36

0.45

1.2

1.3

—

(4198724)

1.40

0.45

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

174

0.75

0.43

1.1

1.0

0.0

0.5

u/ml

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.61

0.43

1.8

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.61

0.43

1.8

1.1

104.6

95.3

—

(4015189)

1.43

0.42

3.8

2.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.56

0.42

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

131

1.30

0.42

1.0

31.3

47.8

ng/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

173

0.75

0.42

1.2

1.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.41

0.0

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.40

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

259

0.81

0.39

1.1

0.9

1.7

u/ml

—

119

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

277

2907

0.95

0.37

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

245

0.81

0.36

1.1

3.8

2.7

u/ml

—

(4024509)

212

0.80

0.35

1.8

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

742

0.90

0.34

1.5

1.8

—

(44806420)

1.35

0.31

2.1

2.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

129

1.24

0.30

1.0

386.8

336.3

ng/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.27

0.27

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

263

1.14

0.25

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.23

0.25

1.0

—

6.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.18

0.24

3.9

1.9

13.1

124.6

ug/l

—

(3015183) Erythrocyte sedimentation rate

0.72

0.24

1.2

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

186

1940

0.96

0.23

1.5

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

136

1430

0.95

0.23

2.3

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

587

0.92

0.22

1.4

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

330

3399

0.97

0.22

3.0

3.1

0.9

0.8

ug/l

1.06

244

2327

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

305

0.88

0.22

1.1

0.7

1.8

u/ml

1.23

132

(4133840)

1.19

0.21

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

12.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

101

0.79

0.21

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.21

0.19

2.2

1.3

1.0

g/l

0.13

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.21

0.17

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

515

5057

1.02

0.17

1.8

1.6

1.5

1.3

mmol/l

4.81

442

4188

(3034426) Prothrombin time (PT)

1.13

0.17

1.1

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.76

0.17

2.8

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

263

1.10

0.16

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.77

0.15

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

119

0.84

0.15

1.1

1.2

—

(44813793)

129

0.85

0.14

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

540

1.06

0.13

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

124

1279

0.97

0.11

2.1

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

188

0.90

0.11

1.1

0.8

4.7

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

597

0.95

0.10

1.5

1.4

—

(4094501)

496

1.05

0.10

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

472

4665

1.01

0.09

4.1

4.3

21.8

21.6

0.09

260

2394

(3035933) Granulocytes/100 leukocytes in Blood

1.05

0.08

1.8

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

145

1482

0.98

0.08

1.4

—

(4281824)

205

1.07

0.08

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

316

1.04

0.05

1.2

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

202

0.94

0.05

1.1

1.0

1.3

3.7

u/ml

—

(3014051) Protein [Presence] in Urine by Test strip

435

0.96

0.05

2.6

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

832

0.99

0.02

1.8

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

187

0.96

0.01

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

542

1.02

0.01

1.9

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

407

0.98

0.01

6.2

3.4

34.7

25.9

mg/l

0.56

247

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

134

1.05

0.00

1.9

1.6

2.1

5.8

ug/l

—

107

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

119

1.01

0.00

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

655

1.01

0.00

2.1

1.7

3.2

3.7

mg/l

0.21

456

(1002224) Polysomnography panel

665

0.99

0.00

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.5

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.87

0.00

1.2

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.6

—

(40768800) Prostate Pathology biopsy report

380

1.00

0.00

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_CA_MET – Disorders of calcium metabolism

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Disorders of calcium metabolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Disorders of calcium metabolism (E4_CA_MET)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints